<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37445926</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>13</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4<sup>+</sup> T Cells-Implications for the Pathogenesis of Systemic Lupus Erythematosus.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10749</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241310749</ELocationID><Abstract><AbstractText>Endocytic recycling regulates the cell surface receptor composition of the plasma membrane. The surface expression levels of the T cell receptor (TCR), in concert with signal transducing co-receptors, regulate T cell responses, such as proliferation, differentiation, and cytokine production. Altered TCR expression contributes to pro-inflammatory skewing, which is a hallmark of autoimmune diseases, such as systemic lupus erythematosus (SLE), defined by a reduced function of regulatory T cells (Tregs) and the expansion of CD4<sup>+</sup> helper T (Th) cells. The ensuing secretion of inflammatory cytokines, such as interferon-&#x3b3; and interleukin (IL)-4, IL-17, IL-21, and IL-23, trigger autoantibody production and tissue infiltration by cells of the adaptive and innate immune system that induce organ damage. Endocytic recycling influences immunological synapse formation by CD4<sup>+</sup> T lymphocytes, signal transduction from crosslinked surface receptors through recruitment of adaptor molecules, intracellular traffic of organelles, and the generation of metabolites to support growth, cytokine production, and epigenetic control of DNA replication and gene expression in the cell nucleus. This review will delineate checkpoints of endosome traffic that can be targeted for therapeutic interventions in autoimmune and other disease conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Joy S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-8211-9950</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Norton College of Medicine, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Norton College of Medicine, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perl</LastName><ForeName>Andras</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Norton College of Medicine, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Norton College of Medicine, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Norton College of Medicine, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AR076092</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011948">Receptors, Antigen, T-Cell</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006377" MajorTopicYN="N">T-Lymphocytes, Helper-Inducer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011948" MajorTopicYN="N">Receptors, Antigen, T-Cell</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011992" MajorTopicYN="N">Endosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD4+ T cells</Keyword><Keyword MajorTopicYN="N">IL-17</Keyword><Keyword MajorTopicYN="N">IL-2</Keyword><Keyword MajorTopicYN="N">JAK/STAT</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">endosome traffic</Keyword><Keyword MajorTopicYN="N">glucose</Keyword><Keyword MajorTopicYN="N">glutamine</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">kynurenine</Keyword><Keyword MajorTopicYN="N">lysosome</Keyword><Keyword MajorTopicYN="N">mTOR</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">tryptophan</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37445926</ArticleId><ArticleId IdType="pmc">PMC10341602</ArticleId><ArticleId IdType="doi">10.3390/ijms241310749</ArticleId><ArticleId IdType="pii">ijms241310749</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zerial M., McBride H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2001;2:107&#x2013;117. doi: 10.1038/35052055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35052055</ArticleId><ArticleId IdType="pubmed">11252952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler D.B., Zoncu R., Root D.E., Sabatini D.M., Sawyers C.L. Identification of an oncogenic RAB protein. Science. 2015;350:211&#x2013;217. doi: 10.1126/science.aaa4903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa4903</ArticleId><ArticleId IdType="pmc">PMC4600465</ArticleId><ArticleId IdType="pubmed">26338797</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzeng H.-T., Wang Y.-C. Rab-mediated vesicle trafficking in cancer. J. Biomed. Sci. 2016;23:70. doi: 10.1186/s12929-016-0287-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-016-0287-7</ArticleId><ArticleId IdType="pmc">PMC5053131</ArticleId><ArticleId IdType="pubmed">27716280</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua C.E.L., Tang B.L. The role of the small GTPase Rab31 in cancer. J. Cell. Mol. Med. 2015;19:1&#x2013;10. doi: 10.1111/jcmm.12403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12403</ArticleId><ArticleId IdType="pmc">PMC4288343</ArticleId><ArticleId IdType="pubmed">25472813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Hu C., Wu F., He S. Rab25 GTPase: Functional roles in cancer. Oncotarget. 2017;8:64591&#x2013;64599. doi: 10.18632/oncotarget.19571.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.19571</ArticleId><ArticleId IdType="pmc">PMC5610028</ArticleId><ArticleId IdType="pubmed">28969096</ArticleId></ArticleIdList></Reference><Reference><Citation>Veleri S., Punnakkal P., Dunbar G.L., Maiti P. Molecular Insights into the Roles of Rab Proteins in Intracellular Dynamics and Neurodegenerative Diseases. Neuromol. Med. 2018;20:18&#x2013;36. doi: 10.1007/s12017-018-8479-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-018-8479-9</ArticleId><ArticleId IdType="pubmed">29423895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiral F.R., Kohrs F.E., Jin E.J., Hiesinger P.R. Rab GTPases and Membrane Trafficking in Neurodegeneration. Curr. Biol. 2018;28:R471&#x2013;R486. doi: 10.1016/j.cub.2018.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.02.010</ArticleId><ArticleId IdType="pmc">PMC5965285</ArticleId><ArticleId IdType="pubmed">29689231</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B.L. Rabs, Membrane Dynamics, and Parkinson&#x2019;s Disease. J. Cell. Physiol. 2017;232:1626&#x2013;1633. doi: 10.1002/jcp.25713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25713</ArticleId><ArticleId IdType="pubmed">27925204</ArticleId></ArticleIdList></Reference><Reference><Citation>Prashar A., Schnettger L., Bernard E.M., Gutierrez M.G. Rab GTPases in Immunity and Inflammation. Front. Cell Infect. Microbiol. 2017;7:435. doi: 10.3389/fcimb.2017.00435.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00435</ArticleId><ArticleId IdType="pmc">PMC5627064</ArticleId><ArticleId IdType="pubmed">29034219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez D.R., Telarico T., Bonilla E., Li Q., Banerjee S., Middleton F.A., Phillips P.E., Crow M.K., Oess S., Muller-Esterl W., et al. Activation of mTOR controls the loss of TCR&#x3b6; in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J. Immunol. 2009;182:2063&#x2013;2073. doi: 10.4049/jimmunol.0803600.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0803600</ArticleId><ArticleId IdType="pmc">PMC2676112</ArticleId><ArticleId IdType="pubmed">19201859</ArticleId></ArticleIdList></Reference><Reference><Citation>Evnouchidou I., Caillens V., Koumantou D., Saveanu L. The role of endocytic trafficking in antigen T cell receptor activation. Biomed. J. 2022;45:310&#x2013;320. doi: 10.1016/j.bj.2021.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2021.09.004</ArticleId><ArticleId IdType="pmc">PMC9250096</ArticleId><ArticleId IdType="pubmed">34592497</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A. Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLE. Clin. Immunol. 2012;142:219. doi: 10.1016/j.clim.2011.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2011.12.011</ArticleId><ArticleId IdType="pmc">PMC4048946</ArticleId><ArticleId IdType="pubmed">22245265</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman L.A., Tsokos G.C. The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity. J. Biomed. Biotechnol. 2010;2010:e740619. doi: 10.1155/2010/740619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/740619</ArticleId><ArticleId IdType="pmc">PMC2896881</ArticleId><ArticleId IdType="pubmed">20625413</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonelli M., Savitskaya A., von Dalwigk K., Steiner C.W., Aletaha D., Smolen J.S., Scheinecker C. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE) Int. Immunol. 2008;20:861&#x2013;868. doi: 10.1093/intimm/dxn044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxn044</ArticleId><ArticleId IdType="pubmed">18469329</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., Nochy D., Debr&#xe9; P., Piette J.-C., Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 2005;175:8392&#x2013;8400. doi: 10.4049/jimmunol.175.12.8392.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.12.8392</ArticleId><ArticleId IdType="pubmed">16339581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006;212:8&#x2013;27. doi: 10.1111/j.0105-2896.2006.00427.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2006.00427.x</ArticleId><ArticleId IdType="pubmed">16903903</ArticleId></ArticleIdList></Reference><Reference><Citation>Josefowicz S.Z., Lu L.-F., Rudensky A.Y. Regulatory T cells: Mechanisms of differentiation and function. Annu. Rev. Immunol. 2012;30:531&#x2013;564. doi: 10.1146/annurev.immunol.25.022106.141623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.25.022106.141623</ArticleId><ArticleId IdType="pmc">PMC6066374</ArticleId><ArticleId IdType="pubmed">22224781</ArticleId></ArticleIdList></Reference><Reference><Citation>Linker-Israeli M., Deans R.J., Wallace D.J., Prehn J., Ozeri-Chen T., Klinenberg J.R. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J. Immunol. 1991;147:117&#x2013;123. doi: 10.4049/jimmunol.147.1.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.147.1.117</ArticleId><ArticleId IdType="pubmed">2051017</ArticleId></ArticleIdList></Reference><Reference><Citation>Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005;201:233&#x2013;240. doi: 10.1084/jem.20041257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041257</ArticleId><ArticleId IdType="pmc">PMC2212798</ArticleId><ArticleId IdType="pubmed">15657292</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGF&#x3b2; in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells. Immunity. 2006;24:179&#x2013;189. doi: 10.1016/j.immuni.2006.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.01.001</ArticleId><ArticleId IdType="pubmed">16473830</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolidis S.A., Lieberman L.A., Kis-Toth K., Crisp&#xed;n J.C., Tsokos G.C. The Dysregulation of Cytokine Networks in Systemic Lupus Erythematosus. J. Interferon Cytokine Res. 2011;31:769&#x2013;779. doi: 10.1089/jir.2011.0029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2011.0029</ArticleId><ArticleId IdType="pmc">PMC3189553</ArticleId><ArticleId IdType="pubmed">21877904</ArticleId></ArticleIdList></Reference><Reference><Citation>King C., Tangye S.G., Mackay C.R. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 2008;26:741&#x2013;766. doi: 10.1146/annurev.immunol.26.021607.090344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.26.021607.090344</ArticleId><ArticleId IdType="pubmed">18173374</ArticleId></ArticleIdList></Reference><Reference><Citation>Mountz J.D., Hsu H.-C., Ballesteros-Tato A. Dysregulation of T Follicular Helper Cells in Lupus. J. Immunol. 2019;202:1649&#x2013;1658. doi: 10.4049/jimmunol.1801150.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1801150</ArticleId><ArticleId IdType="pmc">PMC6402788</ArticleId><ArticleId IdType="pubmed">30833421</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Guo B., Wu H., Tan L., Chang C., Lu Q. Interleukin-17 in systemic lupus erythematosus: A comprehensive review. Autoimmunity. 2015;48:353&#x2013;361. doi: 10.3109/08916934.2015.1037441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2015.1037441</ArticleId><ArticleId IdType="pubmed">25894789</ArticleId></ArticleIdList></Reference><Reference><Citation>Linker-Israeli M., Bakke A.C., Kitridou R.C., Gendler S., Gillis S., Horwitz D.A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE) J. Immunol. 1983;130:2651&#x2013;2655. doi: 10.4049/jimmunol.130.6.2651.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.130.6.2651</ArticleId><ArticleId IdType="pubmed">6222112</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxfield F.R., McGraw T.E. Endocytic recycling. Nat. Rev. Mol. Cell Biol. 2004;5:121&#x2013;132. doi: 10.1038/nrm1315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1315</ArticleId><ArticleId IdType="pubmed">15040445</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant B.D., Donaldson J.G. Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell Biol. 2009;10:597&#x2013;608. doi: 10.1038/nrm2755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2755</ArticleId><ArticleId IdType="pmc">PMC3038567</ArticleId><ArticleId IdType="pubmed">19696797</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitsikas V., Corr&#xea;a I.R., Jr., Nichols B.J. Clathrin-independent pathways do not contribute significantly to endocytic flux. eLife. 2014;3:e03970. doi: 10.7554/eLife.03970.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.03970</ArticleId><ArticleId IdType="pmc">PMC4185422</ArticleId><ArticleId IdType="pubmed">25232658</ArticleId></ArticleIdList></Reference><Reference><Citation>Huotari J., Helenius A. Endosome maturation. EMBO J. 2011;30:3481&#x2013;3500. doi: 10.1038/emboj.2011.286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.286</ArticleId><ArticleId IdType="pmc">PMC3181477</ArticleId><ArticleId IdType="pubmed">21878991</ArticleId></ArticleIdList></Reference><Reference><Citation>Novick P., Zerial M. The diversity of Rab proteins in vesicle transport. Curr. Opin. Cell Biol. 1997;9:496&#x2013;504. doi: 10.1016/S0955-0674(97)80025-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0955-0674(97)80025-7</ArticleId><ArticleId IdType="pubmed">9261061</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr F., Lambright D.G. Rab GEFs and GAPs. Curr. Opin. Cell Biol. 2010;22:461&#x2013;470. doi: 10.1016/j.ceb.2010.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2010.04.007</ArticleId><ArticleId IdType="pmc">PMC2929657</ArticleId><ArticleId IdType="pubmed">20466531</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman R.M., Mellman I.S., Muller W.A., Cohn Z.A. Cohn Endocytosis and the recycling of plasma membrane. J. Cell Biol. 1983;96:1&#x2013;27. doi: 10.1083/jcb.96.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.96.1.1</ArticleId><ArticleId IdType="pmc">PMC2112240</ArticleId><ArticleId IdType="pubmed">6298247</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellman I. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 1996;12:575&#x2013;625. doi: 10.1146/annurev.cellbio.12.1.575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cellbio.12.1.575</ArticleId><ArticleId IdType="pubmed">8970738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Fedoseienko A., Chen B., Burstein E., Jia D., Billadeau D.D. Endosomal Receptor Trafficking: Retromer and Beyond. Traffic. 2018;19:578&#x2013;590. doi: 10.1111/tra.12574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12574</ArticleId><ArticleId IdType="pmc">PMC6043395</ArticleId><ArticleId IdType="pubmed">29667289</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;nnichsen B., De Renzis S., Nielsen E., Rietdorf J., Zerial M. Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J. Cell Biol. 2000;149:901&#x2013;914. doi: 10.1083/jcb.149.4.901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.149.4.901</ArticleId><ArticleId IdType="pmc">PMC2174575</ArticleId><ArticleId IdType="pubmed">10811830</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheff D.R., Daro E.A., Hull M., Mellman I. The receptor recycling pathway contains two distinct populations of early endosomes with different sorting functions. J. Cell Biol. 1999;145:123&#x2013;139. doi: 10.1083/jcb.145.1.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.145.1.123</ArticleId><ArticleId IdType="pmc">PMC2148223</ArticleId><ArticleId IdType="pubmed">10189373</ArticleId></ArticleIdList></Reference><Reference><Citation>Riederer M.A., Soldati T., Shapiro A.D., Lin J., Pfeffer S.R. Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J. Cell Biol. 1994;125:573&#x2013;582. doi: 10.1083/jcb.125.3.573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.125.3.573</ArticleId><ArticleId IdType="pmc">PMC2119986</ArticleId><ArticleId IdType="pubmed">7909812</ArticleId></ArticleIdList></Reference><Reference><Citation>Poteryaev D., Datta S., Ackema K., Zerial M., Spang A. Identification of the switch in early-to-late endosome transition. Cell. 2010;141:497&#x2013;508. doi: 10.1016/j.cell.2010.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.011</ArticleId><ArticleId IdType="pubmed">20434987</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogan J.S. Regulation of glucose transporter translocation in health and diabetes. Annu. Rev. Biochem. 2012;81:507&#x2013;532. doi: 10.1146/annurev-biochem-060109-094246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060109-094246</ArticleId><ArticleId IdType="pubmed">22482906</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorkin A., von Zastrow M. Endocytosis and signalling: Intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 2009;10:609&#x2013;622. doi: 10.1038/nrm2748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2748</ArticleId><ArticleId IdType="pmc">PMC2895425</ArticleId><ArticleId IdType="pubmed">19696798</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorkin A., Von Zastrow M. Signal transduction and endocytosis: Close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 2002;3:600&#x2013;614. doi: 10.1038/nrm883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm883</ArticleId><ArticleId IdType="pubmed">12154371</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M.C., Caswell P.T., Norman J.C. Endocytic recycling pathways: Emerging regulators of cell migration. Curr. Opin. Cell Biol. 2006;18:549&#x2013;557. doi: 10.1016/j.ceb.2006.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2006.08.003</ArticleId><ArticleId IdType="pubmed">16904305</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorvel J.P., Chavrier P., Zerial M., Gruenberg J. rab5 controls early endosome fusion in vitro. Cell. 1991;64:915&#x2013;925. doi: 10.1016/0092-8674(91)90316-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90316-Q</ArticleId><ArticleId IdType="pubmed">1900457</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucci C., Parton R.G., Mather I.H., Stunnenberg H., Simons K., Hoflack B., Zerial M. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell. 1992;70:715&#x2013;728. doi: 10.1016/0092-8674(92)90306-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90306-W</ArticleId><ArticleId IdType="pubmed">1516130</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi H., Giner A., Hoflack B., Zerial M. A GDP/GTP Exchange-stimulatory Activity for the Rab5-RabGDI Complex on Clathrin-coated Vesicles from Bovine Brain. J. Biol. Chem. 1995;270:11257&#x2013;11262. doi: 10.1074/jbc.270.19.11257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.19.11257</ArticleId><ArticleId IdType="pubmed">7744760</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoforidis S., Miaczynska M., Ashman K., Wilm M., Zhao L., Yip S.C., Waterfield M.D., Backer J.M., Zerial M. Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat. Cell Biol. 1999;1:249&#x2013;252. doi: 10.1038/12075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/12075</ArticleId><ArticleId IdType="pubmed">10559924</ArticleId></ArticleIdList></Reference><Reference><Citation>Schu P.V., Takegawa K., Fry M.J., Stack J.H., Waterfield M.D., Emr S.D. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science. 1993;260:88&#x2013;91. doi: 10.1126/science.8385367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8385367</ArticleId><ArticleId IdType="pubmed">8385367</ArticleId></ArticleIdList></Reference><Reference><Citation>Patki V., Virbasius J., Lane W.S., Toh B.H., Shpetner H.S., Corvera S. Identification of an early endosomal protein regulated by phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA. 1997;94:7326&#x2013;7330. doi: 10.1073/pnas.94.14.7326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.14.7326</ArticleId><ArticleId IdType="pmc">PMC23820</ArticleId><ArticleId IdType="pubmed">9207090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills I.G., Jones A.T., Clague M.J. Involvement of the endosomal autoantigen EEA1 in homotypic fusion of early endosomes. Curr. Biol. 1998;8:881&#x2013;884. doi: 10.1016/S0960-9822(07)00351-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(07)00351-X</ArticleId><ArticleId IdType="pubmed">9705936</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen A., Lipp&#xe9; R., Christoforidis S., Gaullier J.M., Brech A., Callaghan J., Toh B.H., Murphy C., Zerial M., Stenmark H. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature. 1998;394:494&#x2013;498. doi: 10.1038/28879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/28879</ArticleId><ArticleId IdType="pubmed">9697774</ArticleId></ArticleIdList></Reference><Reference><Citation>Christoforidis S., McBride H.M., Burgoyne R.D., Zerial M. The Rab5 effector EEA1 is a core component of endosome docking. Nature. 1999;397:621&#x2013;625. doi: 10.1038/17618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/17618</ArticleId><ArticleId IdType="pubmed">10050856</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumas J.J., Merithew E., Sudharshan E., Rajamani D., Hayes S., Lawe D., Corvera S., Lambright D.G. Multivalent endosome targeting by homodimeric EEA1. Mol. Cell. 2001;8:947&#x2013;958. doi: 10.1016/S1097-2765(01)00385-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(01)00385-9</ArticleId><ArticleId IdType="pubmed">11741531</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawe D.C., Chawla A., Merithew E., Dumas J., Carrington W., Fogarty K., Lifshitz L., Tuft R., Lambright D., Corvera S. Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1. J. Biol. Chem. 2002;277:8611&#x2013;8617. doi: 10.1074/jbc.M109239200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109239200</ArticleId><ArticleId IdType="pubmed">11602609</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride H.M., Rybin V., Murphy C., Giner A., Teasdale R., Zerial M. Oligomeric complexes link Rab5 effectors with NSF and drive membrane fusion via interactions between EEA1 and syntaxin 13. Cell. 1999;98:377&#x2013;386. doi: 10.1016/S0092-8674(00)81966-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81966-2</ArticleId><ArticleId IdType="pubmed">10458612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouranti I., Sachse M., Arouche N., Goud B., Echard A. Rab35 Regulates an Endocytic Recycling Pathway Essential for the Terminal Steps of Cytokinesis. Curr. Biol. 2006;16:1719&#x2013;1725. doi: 10.1016/j.cub.2006.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2006.07.020</ArticleId><ArticleId IdType="pubmed">16950109</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Sharma D.K., Marks D.L., Pagano R.E. Elevated endosomal cholesterol levels in Niemann-Pick cells inhibit rab4 and perturb membrane recycling. Mol. Biol. Cell. 2004;15:4500&#x2013;4511. doi: 10.1091/mbc.e04-05-0432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-05-0432</ArticleId><ArticleId IdType="pmc">PMC519144</ArticleId><ArticleId IdType="pubmed">15292453</ArticleId></ArticleIdList></Reference><Reference><Citation>Yudowski G.A., Puthenveedu M.A., Henry A.G., von Zastrow M. Cargo-Mediated Regulation of a Rapid Rab4-Dependent Recycling Pathway. Mol. Biol. Cell. 2009;20:2774&#x2013;2784. doi: 10.1091/mbc.e08-08-0892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-08-0892</ArticleId><ArticleId IdType="pmc">PMC2688556</ArticleId><ArticleId IdType="pubmed">19369423</ArticleId></ArticleIdList></Reference><Reference><Citation>McCaffrey M.W., Bielli A., Cantalupo G., Mora S., Roberti V., Santillo M., Drummond F., Bucci C. Rab4 affects both recycling and degradative endosomal trafficking. FEBS Lett. 2001;495:21&#x2013;30. doi: 10.1016/S0014-5793(01)02359-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(01)02359-6</ArticleId><ArticleId IdType="pubmed">11322941</ArticleId></ArticleIdList></Reference><Reference><Citation>Nag S., Rani S., Mahanty S., Bissig C., Arora P., Azevedo C., Saiardi A., van der Sluijs P., Delevoye C., van Niel G., et al. Rab4A organizes endosomal domains for sorting cargo to lysosome-related organelles. J. Cell Sci. 2018;131:jcs216226. doi: 10.1242/jcs.216226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.216226</ArticleId><ArticleId IdType="pmc">PMC6151265</ArticleId><ArticleId IdType="pubmed">30154210</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sluijs P., Hull M., Webster P., M&#xe2;le P., Goud B., Mellman I. The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell. 1992;70:729&#x2013;740. doi: 10.1016/0092-8674(92)90307-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90307-X</ArticleId><ArticleId IdType="pubmed">1516131</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Ward J., Mosser D.D., Koncz A., Gergely P., Stancato C., Qian Y., Fernandez D., Niland B., Grossman C.E., et al. Regulation of CD4 Expression via Recycling by HRES-1/RAB4 Controls Susceptibility to HIV Infection. J. Biol. Chem. 2006;281:34574&#x2013;34591. doi: 10.1074/jbc.M606301200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M606301200</ArticleId><ArticleId IdType="pubmed">16935861</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch R., Rinderknecht C.H., Roh S., Lee A.W., Harding J.J., Burster T., Hornell T.M.C., Mellins E.D. Achieving stability through editing and chaperoning: Regulation of MHC class II peptide binding and expression. Immunol. Rev. 2005;207:242&#x2013;260. doi: 10.1111/j.0105-2896.2005.00306.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2005.00306.x</ArticleId><ArticleId IdType="pubmed">16181341</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagattuta K.A., Kang J.B., Nathan A., Pauken K.E., Jonsson A.H., Rao D.A., Sharpe A.H., Ishigaki K., Raychaudhuri S. Repertoire analyses reveal T cell antigen receptor sequence features that influence T cell fate. Nat. Immunol. 2022;23:446&#x2013;457. doi: 10.1038/s41590-022-01129-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01129-x</ArticleId><ArticleId IdType="pmc">PMC8904286</ArticleId><ArticleId IdType="pubmed">35177831</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Montesinos G., L&#xf3;pez-Ortega O., Piedra-Reyes J., Bonifaz L.C., Moreno J. Dynamic Changes in the Intracellular Association of Selected Rab Small GTPases with MHC Class II and DM during Dendritic Cell Maturation. Front. Immunol. 2017;8:340. doi: 10.3389/fimmu.2017.00340.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00340</ArticleId><ArticleId IdType="pmc">PMC5367080</ArticleId><ArticleId IdType="pubmed">28396666</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009;9:581&#x2013;593. doi: 10.1038/nri2567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2567</ArticleId><ArticleId IdType="pubmed">19498381</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzarino D.A., Blier P., Mellman I. The Monomeric Guanosine Triphosphatase rab4 Controls an Essential Step on the Pathway of Receptor-mediated Antigen Processing in B Cells. J. Exp. Med. 1998;188:1769&#x2013;1774. doi: 10.1084/jem.188.10.1769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.188.10.1769</ArticleId><ArticleId IdType="pmc">PMC2212406</ArticleId><ArticleId IdType="pubmed">9815254</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczyk M., Leimgruber E., Segu&#xed;n-Est&#xe9;vez Q., Dunand-Sauthier I., Barras E., Reith W. Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes. Nucleic Acids Res. 2007;35:595&#x2013;605. doi: 10.1093/nar/gkl980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl980</ArticleId><ArticleId IdType="pmc">PMC1802633</ArticleId><ArticleId IdType="pubmed">17175541</ArticleId></ArticleIdList></Reference><Reference><Citation>Schorey J.S., Bhatnagar S. Exosome function: From tumor immunology to pathogen biology. Traffic. 2008;9:871&#x2013;881. doi: 10.1111/j.1600-0854.2008.00734.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2008.00734.x</ArticleId><ArticleId IdType="pmc">PMC3636814</ArticleId><ArticleId IdType="pubmed">18331451</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed I., Akram Z., Iqbal H.M.N., Munn A.L. The regulation of Endosomal Sorting Complex Required for Transport and accessory proteins in multivesicular body sorting and enveloped viral budding&#x2014;An overview. Int. J. Biol. Macromol. 2019;127:1&#x2013;11. doi: 10.1016/j.ijbiomac.2019.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2019.01.015</ArticleId><ArticleId IdType="pubmed">30615963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski M., Carmo N.B., Krumeich S., Fanget I., Raposo G., Savina A., Moita C.F., Schauer K., Hume A.N., Freitas R.P., et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 2010;12:19&#x2013;30. doi: 10.1038/ncb2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2000</ArticleId><ArticleId IdType="pubmed">19966785</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalluri R., LeBleu V.S. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977. doi: 10.1126/science.aau6977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aau6977</ArticleId><ArticleId IdType="pmc">PMC7717626</ArticleId><ArticleId IdType="pubmed">32029601</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith V.L., Cheng Y., Bryant B.R., Schorey J.S. Exosomes function in antigen presentation during an in vivo Mycobacterium tuberculosis infection. Sci. Rep. 2017;7:43578. doi: 10.1038/srep43578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43578</ArticleId><ArticleId IdType="pmc">PMC5338015</ArticleId><ArticleId IdType="pubmed">28262829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L., Zhao M., Wu H., Zhang Y., Tong X., Gao L., Zhou L., Lu Q., Zeng J. Downregulated Serum Exosomal miR-451a Expression Correlates With Renal Damage and Its Intercellular Communication Role in Systemic Lupus Erythematosus. Front. Immunol. 2021;12:630112. doi: 10.3389/fimmu.2021.630112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.630112</ArticleId><ArticleId IdType="pmc">PMC7906989</ArticleId><ArticleId IdType="pubmed">33643314</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks C.R., Freiberg B.A., Kupfer H., Sciaky N., Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 1998;395:82&#x2013;86. doi: 10.1038/25764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/25764</ArticleId><ArticleId IdType="pubmed">9738502</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson G., Moore N.C., Owen J.J.T., Jenkinson E.J. Cellular Interactions in Thymocyte Development. Annu. Rev. Immunol. 1996;14:73&#x2013;99. doi: 10.1146/annurev.immunol.14.1.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.14.1.73</ArticleId><ArticleId IdType="pubmed">8717508</ArticleId></ArticleIdList></Reference><Reference><Citation>Krissansen G.W., Owen M.J., Verbi W., Crumpton M.J. Primary structure of the T3 gamma subunit of the T3/T cell antigen receptor complex deduced from cDNA sequences: Evolution of the T3 gamma and delta subunits. EMBO J. 1986;5:1799&#x2013;1808. doi: 10.1002/j.1460-2075.1986.tb04429.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1986.tb04429.x</ArticleId><ArticleId IdType="pmc">PMC1167043</ArticleId><ArticleId IdType="pubmed">2944745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane L.P., Lin J., Weiss A. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 2000;12:242&#x2013;249. doi: 10.1016/S0952-7915(00)00083-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-7915(00)00083-2</ArticleId><ArticleId IdType="pubmed">10781399</ArticleId></ArticleIdList></Reference><Reference><Citation>Freiberg B.A., Kupfer H., Maslanik W., Delli J., Kappler J., Zaller D.M., Kupfer A. Staging and resetting T cell activation in SMACs. Nat. Immunol. 2002;3:911&#x2013;917. doi: 10.1038/ni836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni836</ArticleId><ArticleId IdType="pubmed">12244310</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista A., Mill&#xe1;n J., Mittelbrunn M., S&#xe1;nchez-Madrid F., Alonso M.A. Recruitment of transferrin receptor to immunological synapse in response to TCR engagement. J. Immunol. 2004;172:6709&#x2013;6714. doi: 10.4049/jimmunol.172.11.6709.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.11.6709</ArticleId><ArticleId IdType="pubmed">15153487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao H., Lin J., Littman D.R., Shaw A.S., Allen P.M. Regulated Movement of CD4 In and Out of the Immunological Synapse1. J. Immunol. 2008;181:8248&#x2013;8257. doi: 10.4049/jimmunol.181.12.8248.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.12.8248</ArticleId><ArticleId IdType="pmc">PMC2857686</ArticleId><ArticleId IdType="pubmed">19050241</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchet J., Del R&#xed;o-I&#xf1;iguez I., V&#xe1;zquez-Ch&#xe1;vez E., Lasserre R., Ag&#xfc;era-Gonz&#xe1;lez S., Cuche C., McCaffrey M.W., Di Bartolo V., Alcover A. Rab11-FIP3 Regulation of Lck Endosomal Traffic Controls TCR Signal Transduction. J. Immunol. 2017;198:2967&#x2013;2978. doi: 10.4049/jimmunol.1600671.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600671</ArticleId><ArticleId IdType="pubmed">28235866</ArticleId></ArticleIdList></Reference><Reference><Citation>Thill P.A., Weiss A., Chakraborty A.K. Phosphorylation of a Tyrosine Residue on Zap70 by Lck and Its Subsequent Binding via an SH2 Domain May Be a Key Gatekeeper of T Cell Receptor Signaling In Vivo. Mol. Cell. Biol. 2016;36:2396&#x2013;2402. doi: 10.1128/MCB.00165-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00165-16</ArticleId><ArticleId IdType="pmc">PMC5007795</ArticleId><ArticleId IdType="pubmed">27354065</ArticleId></ArticleIdList></Reference><Reference><Citation>Samelson L.E. Signal transduction mediated by the T cell antigen receptor: The role of adapter proteins. Annu. Rev. Immunol. 2002;20:371&#x2013;394. doi: 10.1146/annurev.immunol.20.092601.111357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.20.092601.111357</ArticleId><ArticleId IdType="pubmed">11861607</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna S., Zhong X. Role of diacylglycerol kinases in T cell development and function. Crit. Rev. Immunol. 2013;33:97&#x2013;118. doi: 10.1615/CritRevImmunol.2013006696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevImmunol.2013006696</ArticleId><ArticleId IdType="pmc">PMC3689416</ArticleId><ArticleId IdType="pubmed">23582058</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares H., Lasserre R., Alcover A. Orchestrating cytoskeleton and intracellular vesicle traffic to build functional immunological synapses. Immunol. Rev. 2013;256:118&#x2013;132. doi: 10.1111/imr.12110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12110</ArticleId><ArticleId IdType="pubmed">24117817</ArticleId></ArticleIdList></Reference><Reference><Citation>Finetti F., Patrussi L., Masi G., Onnis A., Galgano D., Lucherini O.M., Pazour G.J., Baldari C.T. Specific recycling receptors are targeted to the immune synapse by the intraflagellar transport system. J. Cell Sci. 2014;127:1924&#x2013;1937. doi: 10.1242/jcs.139337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.139337</ArticleId><ArticleId IdType="pmc">PMC4004972</ArticleId><ArticleId IdType="pubmed">24554435</ArticleId></ArticleIdList></Reference><Reference><Citation>Degli Esposti M., Matarrese P., Tinari A., Longo A., Recalchi S., Khosravi-Far R., Malorni W., Misasi R., Garofalo T., Sorice M. Changes in membrane lipids drive increased endocytosis following Fas ligation. Apoptosis. 2017;22:681&#x2013;695. doi: 10.1007/s10495-017-1362-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10495-017-1362-6</ArticleId><ArticleId IdType="pubmed">28299505</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpier J.-M., Zucchetti A.E., Bataille L., Dogniaux S., Shafaq-Zadah M., Bardin S., Lucchino M., Maurin M., Joannas L.D., Magalhaes J.G., et al. Rab6-dependent retrograde traffic of LAT controls immune synapse formation and T cell activation. J. Exp. Med. 2018;215:1245&#x2013;1265. doi: 10.1084/jem.20162042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20162042</ArticleId><ArticleId IdType="pmc">PMC5881459</ArticleId><ArticleId IdType="pubmed">29440364</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Mancha N., Rodr&#xed;guez-Rodr&#xed;guez C., Alcover A., Merida I. Sorting Nexin 27 Enables MTOC and Secretory Machinery Translocation to the Immune Synapse. Front. Immunol. 2022;12:814570. doi: 10.3389/fimmu.2021.814570.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.814570</ArticleId><ArticleId IdType="pmc">PMC8790036</ArticleId><ArticleId IdType="pubmed">35095913</ArticleId></ArticleIdList></Reference><Reference><Citation>Temkin P., Lauffer B., J&#xe4;ger S., Cimermancic P., Krogan N.J., von Zastrow M. SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors. Nat. Cell Biol. 2011;13:715&#x2013;721. doi: 10.1038/ncb2252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2252</ArticleId><ArticleId IdType="pmc">PMC3113693</ArticleId><ArticleId IdType="pubmed">21602791</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P.-M., Tsokos G.C. The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: An update. Curr. Opin. Rheumatol. 2021;33:586&#x2013;591. doi: 10.1097/BOR.0000000000000815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000815</ArticleId><ArticleId IdType="pmc">PMC8567317</ArticleId><ArticleId IdType="pubmed">34183542</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z., Bai L., Li W., Zeng T., Tian H., Cui J. Targeting T cell metabolism in the tumor microenvironment: An anti-cancer therapeutic strategy. J. Exp. Clin. Cancer Res. 2019;38:403. doi: 10.1186/s13046-019-1409-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-019-1409-3</ArticleId><ArticleId IdType="pmc">PMC6743108</ArticleId><ArticleId IdType="pubmed">31519198</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss K., Sewell A.E., Krystofiak E.S., Gibson-Corley K.N., Young A.C., Basham J.H., Sugiura A., Arner E.N., Beavers W.N., Kunkle D.E., et al. Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus. Sci. Immunol. 2023;8:eabq0178. doi: 10.1126/sciimmunol.abq0178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abq0178</ArticleId><ArticleId IdType="pmc">PMC9936798</ArticleId><ArticleId IdType="pubmed">36638190</ArticleId></ArticleIdList></Reference><Reference><Citation>Enyedy E.J., Nambiar M.P., Liossis S.N., Dennis G., Kammer G.M., Tsokos G.C. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44:1114&#x2013;1121. doi: 10.1002/1529-0131(200105)44:5&lt;1114::AID-ANR192&gt;3.0.CO;2-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200105)44:5&lt;1114::AID-ANR192&gt;3.0.CO;2-B</ArticleId><ArticleId IdType="pubmed">11352243</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi T., Suzuki K., Kondo T., Yoshimoto K., Tsuzaka K. CD3 &#x3b6; defects in systemic lupus erythematosus. Ann. Rheum. Dis. 2012;71:i78&#x2013;i81. doi: 10.1136/annrheumdis-2011-200641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2011-200641</ArticleId><ArticleId IdType="pubmed">22460144</ArticleId></ArticleIdList></Reference><Reference><Citation>Takai T. Fc receptors and their role in immune regulation and autoimmunity. J. Clin. Immunol. 2005;25:1&#x2013;18. doi: 10.1007/s10875-005-0353-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-005-0353-8</ArticleId><ArticleId IdType="pubmed">15742153</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.P., Lin W.J., Huang M., Kappler J.W., Marrack P. Development and function of T cells in T cell antigen receptor/CD3 zeta knockout mice reconstituted with Fc epsilon RI gamma. Proc. Natl. Acad. Sci. USA. 1997;94:616&#x2013;621. doi: 10.1073/pnas.94.2.616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.2.616</ArticleId><ArticleId IdType="pmc">PMC19562</ArticleId><ArticleId IdType="pubmed">9012833</ArticleId></ArticleIdList></Reference><Reference><Citation>Liossis S.N., Ding X.Z., Dennis G.J., Tsokos G.C. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J. Clin. Investig. 1998;101:1448&#x2013;1457. doi: 10.1172/JCI1457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI1457</ArticleId><ArticleId IdType="pmc">PMC508723</ArticleId><ArticleId IdType="pubmed">9525988</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan S., Warke V.G., Nambiar M.P., Tsokos G.C., Farber D.L. The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. J. Immunol. 2003;170:4189&#x2013;4195. doi: 10.4049/jimmunol.170.8.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.8.4189</ArticleId><ArticleId IdType="pubmed">12682251</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi O.H., Kim J.-H. Calcium mobilization via sphingosine kinase in signalling by the FctRI antigen receptor. Nature. 1996;380:634&#x2013;636. doi: 10.1038/380634a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/380634a0</ArticleId><ArticleId IdType="pubmed">8602265</ArticleId></ArticleIdList></Reference><Reference><Citation>Savina A., Furl&#xe1;n M., Vidal M., Colombo M.I. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J. Biol. Chem. 2003;278:20083&#x2013;20090. doi: 10.1074/jbc.M301642200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M301642200</ArticleId><ArticleId IdType="pubmed">12639953</ArticleId></ArticleIdList></Reference><Reference><Citation>Feske S., Wulff H., Skolnik E.Y. Ion channels in innate and adaptive immunity. Annu. Rev. Immunol. 2015;33:291&#x2013;353. doi: 10.1146/annurev-immunol-032414-112212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032414-112212</ArticleId><ArticleId IdType="pmc">PMC4822408</ArticleId><ArticleId IdType="pubmed">25861976</ArticleId></ArticleIdList></Reference><Reference><Citation>Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S.-H., Tanasa B., Hogan P.G., Lewis R.S., Daly M., Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006;441:179&#x2013;185. doi: 10.1038/nature04702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04702</ArticleId><ArticleId IdType="pubmed">16582901</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Srinivasan P., Razavi S., Seymour S., Meraner P., Gudlur A., Stathopulos P.B., Ikura M., Rao A., Hogan P.G. Initial activation of STIM1, the regulator of store-operated calcium entry. Nat. Struct. Mol. Biol. 2013;20:973&#x2013;981. doi: 10.1038/nsmb.2625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2625</ArticleId><ArticleId IdType="pmc">PMC3784406</ArticleId><ArticleId IdType="pubmed">23851458</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza L.B., Ong H.L., Liu X., Ambudkar I.S. Fast endocytic recycling determines TRPC1-STIM1 clustering in ER-PM junctions and plasma membrane function of the channel. Biochim. Biophys. Acta. 2015;1853:2709&#x2013;2721. doi: 10.1016/j.bbamcr.2015.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2015.07.019</ArticleId><ArticleId IdType="pubmed">26232624</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Panicker S., Lau K.-Y., Apparsundaram S., Patel V.A., Chen S.-L., Soto R., Jung J.K.C., Ravindran P., Okuhara D., et al. Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions. Mol. Immunol. 2013;54:355&#x2013;367. doi: 10.1016/j.molimm.2012.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2012.12.011</ArticleId><ArticleId IdType="pubmed">23357789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Huynh W., Skokan T.D., Lu W., Weiss A., Vale R.D. CRACR2a is a calcium-activated dynein adaptor protein that regulates endocytic traffic. J. Cell Biol. 2019;218:1619&#x2013;1633. doi: 10.1083/jcb.201806097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201806097</ArticleId><ArticleId IdType="pmc">PMC6504896</ArticleId><ArticleId IdType="pubmed">30814157</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B., Rice L., Shrimpton J., Lawless D., Walker K., Carter C., McKeown L., Anwar R., Doody G.M., Srikanth S., et al. Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder. Elife. 2021;10:e72559. doi: 10.7554/eLife.72559.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.72559</ArticleId><ArticleId IdType="pmc">PMC8673834</ArticleId><ArticleId IdType="pubmed">34908525</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce E.L., Pearce E.J. Metabolic Pathways in Immune Cell Activation and Quiescence. Immunity. 2013;38:633&#x2013;643. doi: 10.1016/j.immuni.2013.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.04.005</ArticleId><ArticleId IdType="pmc">PMC3654249</ArticleId><ArticleId IdType="pubmed">23601682</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng X., Cornaby C., Li W., Morel L. Metabolic regulation of pathogenic autoimmunity: Therapeutic targeting. Curr. Opin. Immunol. 2019;61:10&#x2013;16. doi: 10.1016/j.coi.2019.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2019.07.001</ArticleId><ArticleId IdType="pmc">PMC6901716</ArticleId><ArticleId IdType="pubmed">31422315</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharabi A., Tsokos G.C. T cell metabolism: New insights in systemic lupus erythematosus pathogenesis and therapy. Nat. Rev. Rheumatol. 2020;16:100&#x2013;112. doi: 10.1038/s41584-019-0356-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-019-0356-x</ArticleId><ArticleId IdType="pubmed">31949287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieman H.L., Wofford J.A., Rathmell J.C. Cytokine Stimulation Promotes Glucose Uptake via Phosphatidylinositol-3 Kinase/Akt Regulation of Glut1 Activity and Trafficking. MBoC. 2007;18:1437&#x2013;1446. doi: 10.1091/mbc.e06-07-0593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e06-07-0593</ArticleId><ArticleId IdType="pmc">PMC1838986</ArticleId><ArticleId IdType="pubmed">17301289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wofford J.A., Wieman H.L., Jacobs S.R., Zhao Y., Rathmell J.C. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood. 2008;111:2101&#x2013;2111. doi: 10.1182/blood-2007-06-096297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-06-096297</ArticleId><ArticleId IdType="pmc">PMC2234050</ArticleId><ArticleId IdType="pubmed">18042802</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng K.W., Agarwal R., Mitra S., Lee J.-S., Carey M., Gray J.W., Mills G.B. Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress. EMBO Mol. Med. 2012;4:125&#x2013;141. doi: 10.1002/emmm.201100193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201100193</ArticleId><ArticleId IdType="pmc">PMC3306554</ArticleId><ArticleId IdType="pubmed">22253197</ArticleId></ArticleIdList></Reference><Reference><Citation>Macintyre A.N., Gerriets V.A., Nichols A.G., Michalek R.D., Rudolph M.C., Deoliveira D., Anderson S.M., Abel E.D., Chen B.J., Hale L.P., et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 2014;20:61&#x2013;72. doi: 10.1016/j.cmet.2014.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.05.004</ArticleId><ArticleId IdType="pmc">PMC4079750</ArticleId><ArticleId IdType="pubmed">24930970</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., Sullivan S.A., Nichols A.G., Rathmell J.C. Cutting edge: Distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 2011;186:3299&#x2013;3303. doi: 10.4049/jimmunol.1003613.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003613</ArticleId><ArticleId IdType="pmc">PMC3198034</ArticleId><ArticleId IdType="pubmed">21317389</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga T., Sato T., Furukawa K., Morimoto S., Endo Y., Umeda M., Sumiyoshi R., Fukui S., Kawashiri S., Iwamoto N., et al. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71:766&#x2013;772. doi: 10.1002/art.40785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40785</ArticleId><ArticleId IdType="pubmed">30462889</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Qu G., Choi S.-C., Cornaby C., Titov A., Kanda N., Teng X., Wang H., Morel L. Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters. Front. Immunol. 2019;10:833. doi: 10.3389/fimmu.2019.00833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00833</ArticleId><ArticleId IdType="pmc">PMC6478810</ArticleId><ArticleId IdType="pubmed">31057554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho P.-C., Bihuniak J.D., Macintyre A.N., Staron M., Liu X., Amezquita R., Tsui Y.-C., Cui G., Micevic G., Perales J.C., et al. Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. Cell. 2015;162:1217&#x2013;1228. doi: 10.1016/j.cell.2015.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.08.012</ArticleId><ArticleId IdType="pmc">PMC4567953</ArticleId><ArticleId IdType="pubmed">26321681</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A., Hanczko R., Telarico T., Oaks Z., Landas S. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase. Trends Mol. Med. 2011;17:395&#x2013;403. doi: 10.1016/j.molmed.2011.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2011.01.014</ArticleId><ArticleId IdType="pmc">PMC3116035</ArticleId><ArticleId IdType="pubmed">21376665</ArticleId></ArticleIdList></Reference><Reference><Citation>Banki K., Hutter E., Colombo E., Gonchoroff N.J., Perl A. Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem. 1996;271:32994&#x2013;33001. doi: 10.1074/jbc.271.51.32994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.51.32994</ArticleId><ArticleId IdType="pubmed">8955144</ArticleId></ArticleIdList></Reference><Reference><Citation>Banki K., Hutter E., Gonchoroff N.J., Perl A. Elevation of Mitochondrial Transmembrane Potential and Reactive Oxygen Intermediate Levels Are Early Events and Occur Independently from Activation of Caspases in Fas Signaling1. J. Immunol. 1999;162:1466&#x2013;1479. doi: 10.4049/jimmunol.162.3.1466.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.162.3.1466</ArticleId><ArticleId IdType="pmc">PMC4020419</ArticleId><ArticleId IdType="pubmed">9973403</ArticleId></ArticleIdList></Reference><Reference><Citation>Gergely P., Grossman C., Niland B., Puskas F., Neupane H., Allam F., Banki K., Phillips P.E., Perl A. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002;46:175&#x2013;190. doi: 10.1002/1529-0131(200201)46:1&lt;175::AID-ART10015&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200201)46:1&lt;175::AID-ART10015&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pmc">PMC4020417</ArticleId><ArticleId IdType="pubmed">11817589</ArticleId></ArticleIdList></Reference><Reference><Citation>Gergely P., Niland B., Gonchoroff N., Pullmann R., Phillips P.E., Perl A. Persistent Mitochondrial Hyperpolarization, Increased Reactive Oxygen Intermediate Production, and Cytoplasmic Alkalinization Characterize Altered IL-10 Signaling in Patients with Systemic Lupus Erythematosus. J. Immunol. 2002;169:1092&#x2013;1101. doi: 10.4049/jimmunol.169.2.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.2.1092</ArticleId><ArticleId IdType="pmc">PMC4020441</ArticleId><ArticleId IdType="pubmed">12097418</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A., Gergely P., Nagy G., Koncz A., Banki K. Mitochondrial hyperpolarization: A checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 2004;25:360&#x2013;367. doi: 10.1016/j.it.2004.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.05.001</ArticleId><ArticleId IdType="pmc">PMC4034110</ArticleId><ArticleId IdType="pubmed">15207503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Z.W., Hanczko R., Bonilla E., Caza T.N., Clair B., Bartos A., Miklossy G., Jimah J., Doherty E., Tily H., et al. N-acetylcysteine reduces disease activity by blocking mTOR in T cells of lupus patients. Arthiritis Rhem. 2012;64:2937&#x2013;2946. doi: 10.1002/art.34502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34502</ArticleId><ArticleId IdType="pmc">PMC3411859</ArticleId><ArticleId IdType="pubmed">22549432</ArticleId></ArticleIdList></Reference><Reference><Citation>Caza T.N., Fernandez D.R., Talaber G., Oaks Z., Haas M., Madaio M.P., Lai Z.-W., Miklossy G., Singh R.R., Chudakov D.M., et al. HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. Ann. Rheum. Dis. 2014;73:1888&#x2013;1897. doi: 10.1136/annrheumdis-2013-203794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203794</ArticleId><ArticleId IdType="pmc">PMC4047212</ArticleId><ArticleId IdType="pubmed">23897774</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw G.C., Cope J.J., Li L., Corson K., Hersey C., Ackermann G.E., Gwynn B., Lambert A.J., Wingert R.A., Traver D., et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006;440:96&#x2013;100. doi: 10.1038/nature04512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04512</ArticleId><ArticleId IdType="pubmed">16511496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wincup C., Sawford N., Rahman A. Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus. Expert. Rev. Clin. Immunol. 2021;17:957&#x2013;967. doi: 10.1080/1744666X.2021.1953981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2021.1953981</ArticleId><ArticleId IdType="pmc">PMC8452144</ArticleId><ArticleId IdType="pubmed">34263712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleven M.D., Jue S., Enns C.A. The Transferrin Receptors, TfR1 and TfR2 Bind Transferrin through Differing Mechanisms. Biochemistry. 2018;57:1552&#x2013;1559. doi: 10.1021/acs.biochem.8b00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.8b00006</ArticleId><ArticleId IdType="pmc">PMC6038944</ArticleId><ArticleId IdType="pubmed">29388418</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Li M.-Y., Gao X.-F., Jia S.-J., Gao K.-Q., Zhou Y., Zhang H.-H., Huang Y., Wang J., Wu H.-J., et al. Downregulation of BDH2 modulates iron homeostasis and promotes DNA demethylation in CD4+ T cells of systemic lupus erythematosus. Clin. Immunol. 2018;187:113&#x2013;121. doi: 10.1016/j.clim.2017.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2017.11.002</ArticleId><ArticleId IdType="pubmed">29113828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Song Y., Wu J., Lu S., Min X., Liu L., Hu L., Zheng M., Du P., Yu Y., et al. Iron-dependent epigenetic modulation promotes pathogenic T cell differentiation in lupus. J. Clin. Investig. 2022;132:e152345. doi: 10.1172/JCI152345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI152345</ArticleId><ArticleId IdType="pmc">PMC9057600</ArticleId><ArticleId IdType="pubmed">35499082</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabara H.H., Boyden S.E., Chou J., Ramesh N., Massaad M.J., Benson H., Bainter W., Fraulino D., Rahimov F., Sieff C., et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat. Genet. 2016;48:74&#x2013;78. doi: 10.1038/ng.3465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3465</ArticleId><ArticleId IdType="pmc">PMC4696875</ArticleId><ArticleId IdType="pubmed">26642240</ArticleId></ArticleIdList></Reference><Reference><Citation>Aljohani A.H., Al-Mousa H., Arnaout R., Al-Dhekri H., Mohammed R., Alsum Z., Nicolas-Jilwan M., Alrogi F., Al-Muhsen S., Alazami A.M., et al. Clinical and Immunological Characterization of Combined Immunodeficiency Due to TFRC Mutation in Eight Patients. J. Clin. Immunol. 2020;40:1103&#x2013;1110. doi: 10.1007/s10875-020-00851-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00851-1</ArticleId><ArticleId IdType="pmc">PMC7449781</ArticleId><ArticleId IdType="pubmed">32851577</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossatti P., Redpath G.M.I., Ziegler L., Samson G.P.B., Clamagirand C.D., Legler D.F., Rossy J. Rapid increase in transferrin receptor recycling promotes adhesion during T cell activation. BMC Biol. 2022;20:189. doi: 10.1186/s12915-022-01386-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-022-01386-0</ArticleId><ArticleId IdType="pmc">PMC9400314</ArticleId><ArticleId IdType="pubmed">36002835</ArticleId></ArticleIdList></Reference><Reference><Citation>Voulgarelis M., Kokori S.I., Ioannidis J.P., Tzioufas A.G., Kyriaki D., Moutsopoulos H.M. Anaemia in systemic lupus erythematosus: Aetiological profile and the role of erythropoietin. Ann. Rheum. Dis. 2000;59:217&#x2013;222. doi: 10.1136/ard.59.3.217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.59.3.217</ArticleId><ArticleId IdType="pmc">PMC1753100</ArticleId><ArticleId IdType="pubmed">10700431</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y., Zhao S., Chen B., Huang Y., Guo C., Li M., Ye B., Wang S., Zhang H., Yang N. Iron controls T helper cell pathogenicity by promoting glucose metabolism in autoimmune myopathy. Clin. Transl. Med. 2022;12:e999. doi: 10.1002/ctm2.999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.999</ArticleId><ArticleId IdType="pmc">PMC9345506</ArticleId><ArticleId IdType="pubmed">35917405</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai S., Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24:464&#x2013;471. doi: 10.1016/j.tcb.2014.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2014.04.002</ArticleId><ArticleId IdType="pmc">PMC4112140</ArticleId><ArticleId IdType="pubmed">24786309</ArticleId></ArticleIdList></Reference><Reference><Citation>Jukarainen S., Heinonen S., R&#xe4;m&#xf6; J.T., Rinnankoski-Tuikka R., Rappou E., Tummers M., Muniandy M., Hakkarainen A., Lundbom J., Lundbom N., et al. Obesity Is Associated With Low NAD+/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins. J. Clin. Endocrinol. Metab. 2016;101:275&#x2013;283. doi: 10.1210/jc.2015-3095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2015-3095</ArticleId><ArticleId IdType="pubmed">26574954</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong B., Pan Y., Vempati P., Zhao W., Knable L., Ho L., Wang J., Sastre M., Ono K., Sauve A.A., et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-&#x3b3; coactivator 1&#x3b1; regulated &#x3b2;-secretase 1 degradation and mitochondrial gene expression in Alzheimer&#x2019;s mouse models. Neurobiol. Aging. 2013;34:1581&#x2013;1588. doi: 10.1016/j.neurobiolaging.2012.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.12.005</ArticleId><ArticleId IdType="pmc">PMC3632303</ArticleId><ArticleId IdType="pubmed">23312803</ArticleId></ArticleIdList></Reference><Reference><Citation>Gujar A.D., Le S., Mao D.D., Dadey D.Y.A., Turski A., Sasaki Y., Aum D., Luo J., Dahiya S., Yuan L., et al. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc. Natl. Acad. Sci. USA. 2016;113:E8247&#x2013;E8256. doi: 10.1073/pnas.1610921114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1610921114</ArticleId><ArticleId IdType="pmc">PMC5187672</ArticleId><ArticleId IdType="pubmed">27930300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy B.E., Sharif T., Martell E., Dai C., Kim Y., Lee P.W.K., Gujar S.A. NAD+ salvage pathway in cancer metabolism and therapy. Pharmacol. Res. 2016;114:274&#x2013;283. doi: 10.1016/j.phrs.2016.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2016.10.027</ArticleId><ArticleId IdType="pubmed">27816507</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama E., Suarez-Fueyo A., Bradley S.J., Mizui M., Marin A.V., Mulki L., Krishfield S., Malavasi F., Yoon J., Ho Sui S.J., et al. The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections. Cell Rep. 2020;30:112&#x2013;123. doi: 10.1016/j.celrep.2019.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.12.014</ArticleId><ArticleId IdType="pmc">PMC7577012</ArticleId><ArticleId IdType="pubmed">31914379</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs H.A., Veech R.L. Equilibrium relations between pyridine nucleotides and adenine nucleotides and their roles in the regulation of metabolic processes. Adv. Enzym. Regul. 1969;7:397&#x2013;413. doi: 10.1016/0065-2571(69)90030-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0065-2571(69)90030-2</ArticleId><ArticleId IdType="pubmed">4391643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Sauve A.A. NAD+ metabolism: Bioenergetics, signaling and manipulation for therapy. Biochim. Biophys. Acta. 2016;1864:1787&#x2013;1800. doi: 10.1016/j.bbapap.2016.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2016.06.014</ArticleId><ArticleId IdType="pmc">PMC5521000</ArticleId><ArticleId IdType="pubmed">27374990</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson K.A., Madsen A.S., Olsen C.A., Hirschey M.D. Metabolic control by sirtuins and other enzymes that sense NAD+, NADH, or their ratio. Biochim. Biophys. Acta. 2017;1858:991&#x2013;998. doi: 10.1016/j.bbabio.2017.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2017.09.005</ArticleId><ArticleId IdType="pmc">PMC5648639</ArticleId><ArticleId IdType="pubmed">28947253</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher R.S., Lavery G.G. The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism. J. Mol. Endocrinol. 2018;61:R107&#x2013;R121. doi: 10.1530/JME-18-0085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JME-18-0085</ArticleId><ArticleId IdType="pmc">PMC6145238</ArticleId><ArticleId IdType="pubmed">30307159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalkiadaki A., Guarente L. The multifaceted functions of sirtuins in cancer. Nat. Rev. Cancer. 2015;15:608&#x2013;624. doi: 10.1038/nrc3985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3985</ArticleId><ArticleId IdType="pubmed">26383140</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacarelli T., Zhang R. NAD+ metabolism controls inflammation during senescence. Mol. Cell Oncol. 2019;6:1605819. doi: 10.1080/23723556.2019.1605819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23723556.2019.1605819</ArticleId><ArticleId IdType="pmc">PMC6548475</ArticleId><ArticleId IdType="pubmed">31211232</ArticleId></ArticleIdList></Reference><Reference><Citation>Poljsak B. NAD+ in Cancer Prevention and Treatment: Pros and Cons. J. Clin. Exp. Oncol. 2018;2016:2. doi: 10.4172/2324-9110.1000165.</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2324-9110.1000165</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000;403:795&#x2013;800. doi: 10.1038/35001622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35001622</ArticleId><ArticleId IdType="pubmed">10693811</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambon P., Weill J.D., Mandel P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem. Biophys. Res. Commun. 1963;11:39&#x2013;43. doi: 10.1016/0006-291X(63)90024-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(63)90024-X</ArticleId><ArticleId IdType="pubmed">14019961</ArticleId></ArticleIdList></Reference><Reference><Citation>De Flora A., Zocchi E., Guida L., Franco L., Bruzzone S. Autocrine and paracrine calcium signaling by the CD38/NAD+/cyclic ADP-ribose system. Ann. N. Y. Acad. Sci. 2004;1028:176&#x2013;191. doi: 10.1196/annals.1322.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1322.021</ArticleId><ArticleId IdType="pubmed">15650244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottiger M.O., Hassa P.O., L&#xfc;scher B., Sch&#xfc;ler H., Koch-Nolte F. Toward a unified nomenclature for mammalian ADP-ribosyltransferases. Trends Biochem. Sci. 2010;35:208&#x2013;219. doi: 10.1016/j.tibs.2009.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2009.12.003</ArticleId><ArticleId IdType="pubmed">20106667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ijichi H., Ichiyama A., Hayaishi O. Studies on the biosynthesis of nicotinamide adenine dinucleotide. 3. Comparative in vivo studies on nicotinic acid, nicotinamide, and quinolinic acid as precursors of nicotinamide adenine dinucleotide. J. Biol. Chem. 1966;241:3701&#x2013;3707. doi: 10.1016/S0021-9258(18)99829-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)99829-7</ArticleId><ArticleId IdType="pubmed">4288134</ArticleId></ArticleIdList></Reference><Reference><Citation>Navas L.E., Carnero A. NAD+ metabolism, stemness, the immune response, and cancer. Sig Transduct. Target. 2021;6:2. doi: 10.1038/s41392-020-00354-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00354-w</ArticleId><ArticleId IdType="pmc">PMC7775471</ArticleId><ArticleId IdType="pubmed">33384409</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair L.V., Neyens D., Ramsay G., Taylor P.M., Cantrell D.A. Single cell analysis of kynurenine and System L amino acid transport in T cells. Nat. Commun. 2018;9:1981. doi: 10.1038/s41467-018-04366-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04366-7</ArticleId><ArticleId IdType="pmc">PMC5958064</ArticleId><ArticleId IdType="pubmed">29773791</ArticleId></ArticleIdList></Reference><Reference><Citation>Widner B., Sepp N., Kowald E., Kind S., Schmuth M., Fuchs D. Degradation of tryptophan in patients with systemic lupus erythematosus. Adv. Exp. Med. Biol. 1999;467:571&#x2013;577. doi: 10.1007/978-1-4615-4709-9_71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4615-4709-9_71</ArticleId><ArticleId IdType="pubmed">10721102</ArticleId></ArticleIdList></Reference><Reference><Citation>Widner B., Sepp N., Kowald E., Ortner U., Wirleitner B., Fritsch P., Baier-Bitterlich G., Fuchs D. Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology. 2000;201:621&#x2013;630. doi: 10.1016/S0171-2985(00)80079-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0171-2985(00)80079-0</ArticleId><ArticleId IdType="pubmed">10834318</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaks Z., Perl A. Metabolic control of the epigenome in systemic Lupus erythematosus. Autoimmunity. 2014;47:256&#x2013;264. doi: 10.3109/08916934.2013.834495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2013.834495</ArticleId><ArticleId IdType="pmc">PMC4034124</ArticleId><ArticleId IdType="pubmed">24128087</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y., Choi S.-C., Xu Z., Perry D.J., Seay H., Croker B.P., Sobel E.S., Brusko T.M., Morel L. Normalization of CD4+ T Cell Metabolism Reverses Lupus. Sci. Transl. Med. 2015;7:274ra18. doi: 10.1126/scitranslmed.aaa0835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa0835</ArticleId><ArticleId IdType="pmc">PMC5292723</ArticleId><ArticleId IdType="pubmed">25673763</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado-B&#xe1;ez L., Cole N.B., Kr&#xe4;mer H., Donaldson J.G. Microtubule-dependent endosomal sorting of clathrin-independent cargo by Hook1. J. Cell Biol. 2013;201:233&#x2013;247. doi: 10.1083/jcb.201208172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201208172</ArticleId><ArticleId IdType="pmc">PMC3628520</ArticleId><ArticleId IdType="pubmed">23589492</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.-C., Brown J., Gong M., Ge Y., Zadeh M., Li W., Croker B.P., Michailidis G., Garrett T.J., Mohamadzadeh M., et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci. Transl. Med. 2020;12:eaax2220. doi: 10.1126/scitranslmed.aax2220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aax2220</ArticleId><ArticleId IdType="pmc">PMC7739186</ArticleId><ArticleId IdType="pubmed">32641487</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J., Abboud G., Ma L., Choi S.-C., Kanda N., Zeumer-Spataro L., Lee J., Peng W., Cagmat J., Faludi T., et al. Microbiota-mediated skewing of tryptophan catabolism modulates CD4+ T cells in lupus-prone mice. iScience. 2022;25:104241. doi: 10.1016/j.isci.2022.104241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104241</ArticleId><ArticleId IdType="pmc">PMC9051618</ArticleId><ArticleId IdType="pubmed">35494242</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A., Hanczko R., Lai Z.W., Oaks Z., Kelly R., Borsuk R., Asara J.M., Phillips P.E. Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: Implications for activation of the mechanistic target of rapamycin. Metabolomics. 2015;11:1157&#x2013;1174. doi: 10.1007/s11306-015-0772-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0772-0</ArticleId><ArticleId IdType="pmc">PMC4559110</ArticleId><ArticleId IdType="pubmed">26366134</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Z.W., Borsuk R., Shadakshari A., Yu J., Dawood M., Garcia R., Francis L., Tily H., Bartos A., Faraone S.V., et al. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J. Immunol. 2013;191:2236&#x2013;2246. doi: 10.4049/jimmunol.1301005.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301005</ArticleId><ArticleId IdType="pmc">PMC3777662</ArticleId><ArticleId IdType="pubmed">23913957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Z.-W., Kelly R., Winans T., Marchena I., Shadakshari A., Yu J., Dawood M., Garcia R., Tily H., Francis L., et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: A single-arm, open-label, phase 1/2 trial. Lancet. 2018;391:1186&#x2013;1196. doi: 10.1016/S0140-6736(18)30485-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30485-9</ArticleId><ArticleId IdType="pmc">PMC5891154</ArticleId><ArticleId IdType="pubmed">29551338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., Perl A. The IL-21-mtor axis blocks treg differentiation and function by suppression of autophagy in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2018;70:427. doi: 10.1002/art.40380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40380</ArticleId><ArticleId IdType="pmc">PMC5826851</ArticleId><ArticleId IdType="pubmed">29161463</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T.-T., Gomez T.S., Sackey B.K., Billadeau D.D., Burd C.G. Rab GTPase regulation of retromer-mediated cargo export during endosome maturation. Mol. Biol. Cell. 2012;23:2505&#x2013;2515. doi: 10.1091/mbc.e11-11-0915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e11-11-0915</ArticleId><ArticleId IdType="pmc">PMC3386214</ArticleId><ArticleId IdType="pubmed">22593205</ArticleId></ArticleIdList></Reference><Reference><Citation>Curnock R., Calcagni A., Ballabio A., Cullen P.J. TFEB controls retromer expression in response to nutrient availability. J. Cell Biol. 2019;218:3954&#x2013;3966. doi: 10.1083/jcb.201903006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201903006</ArticleId><ArticleId IdType="pmc">PMC6891082</ArticleId><ArticleId IdType="pubmed">31694921</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaya M., Xiao Y., Zhou X., Chang J.-H., Chang M., Cheng X., Blonska M., Lin X., Sun S.-C. Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity. 2014;40:692&#x2013;705. doi: 10.1016/j.immuni.2014.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.04.007</ArticleId><ArticleId IdType="pmc">PMC4074507</ArticleId><ArticleId IdType="pubmed">24792914</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz F., Povey S., Parkar M., Schneider C., Sutherland R., Stanley K., Solomon E., Greaves M. Chromosome assignment of monoclonal antibody-defined determinants on human leukemic cells. Eur. J. Immunol. 1983;13:1008&#x2013;1013. doi: 10.1002/eji.1830131211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830131211</ArticleId><ArticleId IdType="pubmed">6198179</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraoka O., Tanaka H., Itoh M., Ishihara K., Hirano T. Genomic structure of human BST-1. Immunol. Lett. 1996;54:1&#x2013;4. doi: 10.1016/S0165-2478(96)02633-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-2478(96)02633-8</ArticleId><ArticleId IdType="pubmed">9030974</ArticleId></ArticleIdList></Reference><Reference><Citation>Aarhus R., Graeff R.M., Dickey D.M., Walseth T.F., Hon C.L. ADP-ribosyl Cyclase and CD38 Catalyze the Synthesis of a Calcium-mobilizing Metabolite from NADP+(&#x2217;) J. Biol. Chem. 1995;270:30327&#x2013;30333. doi: 10.1074/jbc.270.51.30327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.51.30327</ArticleId><ArticleId IdType="pubmed">8530456</ArticleId></ArticleIdList></Reference><Reference><Citation>Malavasi F., Deaglio S., Funaro A., Ferrero E., Horenstein A.L., Ortolan E., Vaisitti T., Aydin S. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 2008;88:841&#x2013;886. doi: 10.1152/physrev.00035.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00035.2007</ArticleId><ArticleId IdType="pubmed">18626062</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarona V., Zaccarello G., Chillemi A., Brunetti E., Singh V.K., Ferrero E., Funaro A., Horenstein A.L., Malavasi F. CD38 and CD157: A long journey from activation markers to multifunctional molecules. Cytom. Part B Clin. Cytom. 2013;84B:207&#x2013;217. doi: 10.1002/cyto.b.21092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.b.21092</ArticleId><ArticleId IdType="pubmed">23576305</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksoy P., White T.A., Thompson M., Chini E.N. Regulation of intracellular levels of NAD: A novel role for CD38. Biochem. Biophys. Res. Commun. 2006;345:1386&#x2013;1392. doi: 10.1016/j.bbrc.2006.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.05.042</ArticleId><ArticleId IdType="pubmed">16730329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhan A.K., Reinherz E.L., Poppema S., McCluskey R.T., Schlossman S.F. Location of T cell and major histocompatibility complex antigens in the human thymus. J. Exp. Med. 1980;152:771&#x2013;782. doi: 10.1084/jem.152.4.771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.152.4.771</ArticleId><ArticleId IdType="pmc">PMC2185965</ArticleId><ArticleId IdType="pubmed">6158549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortolan E., Augeri S., Fissolo G., Musso I., Funaro A. CD157: From immunoregulatory protein to potential therapeutic target. Immunol. Lett. 2019;205:59&#x2013;64. doi: 10.1016/j.imlet.2018.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2018.06.007</ArticleId><ArticleId IdType="pubmed">29936181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B.O., Ishihara K., Denno K., Kobune Y., Itoh M., Muraoka O., Kaisho T., Sasaki T., Ochi T., Hirano T. Elevated levels of the soluble form of bone marrow stromal cell antigen 1 in the sera of patients with severe rheumatoid arthritis. Arthritis Rheum. 1996;39:629&#x2013;637. doi: 10.1002/art.1780390414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780390414</ArticleId><ArticleId IdType="pubmed">8630113</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandelwal P., Lane A., Chaturvedi V., Owsley E., Davies S.M., Marmer D., Filipovich A.H., Jordan M.B., Marsh R.A. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease. Biol. Blood Marrow Transplant. 2015;21:1215&#x2013;1222. doi: 10.1016/j.bbmt.2015.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbmt.2015.04.010</ArticleId><ArticleId IdType="pubmed">25881755</ArticleId></ArticleIdList></Reference><Reference><Citation>Joosse M.E., Menckeberg C.L., de Ruiter L.F., Raatgeep H.C., van Berkel L.A., Simons-Oosterhuis Y., Tindemans I., Muskens A.M., Hendriks R.W., Hoogenboezem R.M., et al. Frequencies of circulating regulatory TIGIT+CD38+ effector T cells correlate with the course of inflammatory bowel disease. Mucosal Immunol. 2019;12:154&#x2013;163. doi: 10.1038/s41385-018-0078-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-018-0078-4</ArticleId><ArticleId IdType="pubmed">30127383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pav&#xf3;n E.J., Zumaquero E., Rosal-Vela A., Khoo K.-M., Cerezo-Wallis D., Garc&#xed;a-Rodr&#xed;guez S., Carrascal M., Abian J., Graeff R., Callejas-Rubio J.-L., et al. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Cytokine. 2013;62:232&#x2013;243. doi: 10.1016/j.cyto.2013.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2013.02.023</ArticleId><ArticleId IdType="pubmed">23538292</ArticleId></ArticleIdList></Reference><Reference><Citation>Chini E.N. CD38 as a regulator of cellular NAD: A novel potential pharmacological target for metabolic conditions. Curr. Pharm. Des. 2009;15:57&#x2013;63. doi: 10.2174/138161209787185788.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161209787185788</ArticleId><ArticleId IdType="pmc">PMC2883294</ArticleId><ArticleId IdType="pubmed">19149603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Jacobson E.L., Jacobson M.K. Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolases. Science. 1993;261:1330&#x2013;1333. doi: 10.1126/science.8395705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8395705</ArticleId><ArticleId IdType="pubmed">8395705</ArticleId></ArticleIdList></Reference><Reference><Citation>Zielinska W., Barata H., Chini E.N. Metabolism of cyclic ADP-ribose: Zinc is an endogenous modulator of the cyclase/NAD glycohydrolase ratio of a CD38-like enzyme from human seminal fluid. Life Sci. 2004;74:1781&#x2013;1790. doi: 10.1016/j.lfs.2003.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2003.08.033</ArticleId><ArticleId IdType="pubmed">14741735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar A., Mehrotra S., Chatterjee S. CD38: T Cell Immuno-Metabolic Modulator. Cells. 2020;9:1716. doi: 10.3390/cells9071716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071716</ArticleId><ArticleId IdType="pmc">PMC7408359</ArticleId><ArticleId IdType="pubmed">32709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Funaro A., Reini&#x161; M., Trubiani O., Santi S., Di Primio R., Malavasi F. CD38 Functions Are Regulated Through an Internalization Step1. J. Immunol. 1998;160:2238&#x2013;2247. doi: 10.4049/jimmunol.160.5.2238.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.160.5.2238</ArticleId><ArticleId IdType="pubmed">9498763</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz P., Mittelbrunn M., de la Fuente H., P&#xe9;rez-Mart&#xed;nez M., Garc&#xed;a-P&#xe9;rez A., Ariza-Veguillas A., Malavasi F., Zubiaur M., S&#xe1;nchez-Madrid F., Sancho J. Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse. Blood. 2008;111:3653&#x2013;3664. doi: 10.1182/blood-2007-07-101600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-07-101600</ArticleId><ArticleId IdType="pubmed">18212246</ArticleId></ArticleIdList></Reference><Reference><Citation>Allard B., Turcotte M., Stagg J. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer. Expert Opin. Ther. Targets. 2014;18:863&#x2013;881. doi: 10.1517/14728222.2014.915315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14728222.2014.915315</ArticleId><ArticleId IdType="pubmed">24798880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosza&#x142;ka P., Go&#x142;u&#x144;ska M., Stanis&#x142;awowski M., Urban A., Stasi&#x142;oj&#x107; G., Majewski M., Wierzbicki P., Sk&#x142;adanowski A.C., Bigda J. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis. Int. J. Biochem. Cell Biol. 2015;69:1&#x2013;10. doi: 10.1016/j.biocel.2015.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2015.10.003</ArticleId><ArticleId IdType="pubmed">26545615</ArticleId></ArticleIdList></Reference><Reference><Citation>Turcotte M., Spring K., Pommey S., Chouinard G., Cousineau I., George J., Chen G.M., Gendoo D.M.A., Haibe-Kains B., Karn T., et al. CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancer Res. 2015;75:4494&#x2013;4503. doi: 10.1158/0008-5472.CAN-14-3569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-14-3569</ArticleId><ArticleId IdType="pubmed">26363007</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesse J., Siekierka-Harreis M., Steckel B., Alter C., Schallehn M., Honke N., Schnieringer M.-L., Wippich M., Braband R., Schneider M., et al. Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients. EBioMedicine. 2021;73:103616. doi: 10.1016/j.ebiom.2021.103616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103616</ArticleId><ArticleId IdType="pmc">PMC8524755</ArticleId><ArticleId IdType="pubmed">34666225</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Li X., Li X., Wang G., Ma Y., Zhao S., Zheng S. Expression of FOXP3 in CD4+ CD39+ T cells of patients with systemic lupus erythematosus and dynamic observation of treatment with glucocorticoid. Zhonghua Yi Xue Za Zhi. 2009;89:1636&#x2013;1638.</Citation><ArticleIdList><ArticleId IdType="pubmed">19957514</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Li X., Zhang J., Hu S., Xiao B., Chen W., Zeng X. The expression of CD73 in CD4+ regulatory T cells in patients with new-onset systemic lupus erythematosus. Zhonghua Nei Ke Za Zhi. 2010;49:772&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pubmed">21092450</ArticleId></ArticleIdList></Reference><Reference><Citation>Grozio A., Sociali G., Sturla L., Caffa I., Soncini D., Salis A., Raffaelli N., De Flora A., Nencioni A., Bruzzone S. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. J. Biol. Chem. 2013;288:25938&#x2013;25949. doi: 10.1074/jbc.M113.470435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.470435</ArticleId><ArticleId IdType="pmc">PMC3764798</ArticleId><ArticleId IdType="pubmed">23880765</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociali G., Raffaghello L., Magnone M., Zamporlini F., Emionite L., Sturla L., Bianchi G., Vigliarolo T., Nahimana A., Nencioni A., et al. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model. Oncotarget. 2016;7:2968&#x2013;2984. doi: 10.18632/oncotarget.6502.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6502</ArticleId><ArticleId IdType="pmc">PMC4823084</ArticleId><ArticleId IdType="pubmed">26658104</ArticleId></ArticleIdList></Reference><Reference><Citation>Garavaglia S., Bruzzone S., Cassani C., Canella L., Allegrone G., Sturla L., Mannino E., Millo E., De Flora A., Rizzi M. The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism. Biochem. J. 2012;441:131&#x2013;141. doi: 10.1042/BJ20111263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20111263</ArticleId><ArticleId IdType="pubmed">21933152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratajczak J., Joffraud M., Trammell S.A.J., Ras R., Canela N., Boutant M., Kulkarni S.S., Rodrigues M., Redpath P., Migaud M.E., et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat. Commun. 2016;7:13103. doi: 10.1038/ncomms13103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13103</ArticleId><ArticleId IdType="pmc">PMC5476803</ArticleId><ArticleId IdType="pubmed">27725675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk A., Hayat F., Cunningham R., Li J., Garavaglia S., Zamani L., Ferraris D.M., Sykora P., Andrews J., Clark J., et al. Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity. Sci. Rep. 2020;10:651. doi: 10.1038/s41598-020-57506-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-57506-9</ArticleId><ArticleId IdType="pmc">PMC6971268</ArticleId><ArticleId IdType="pubmed">31959836</ArticleId></ArticleIdList></Reference><Reference><Citation>Romio M., Reinbeck B., Bongardt S., H&#xfc;ls S., Burghoff S., Schrader J. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am. J. Physiol. Cell Physiol. 2011;301:C530&#x2013;C539. doi: 10.1152/ajpcell.00385.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00385.2010</ArticleId><ArticleId IdType="pubmed">21593451</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth L.A., Ratnasothy K., Tsang J.Y.S., Boardman D., Warley A., Lechler R., Lombardi G. CD73 expression on extracellular vesicles derived from CD4+CD25+Foxp3+ T cells contributes to their regulatory function. Eur. J. Immunol. 2013;43:2430&#x2013;2440. doi: 10.1002/eji.201242909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201242909</ArticleId><ArticleId IdType="pubmed">23749427</ArticleId></ArticleIdList></Reference><Reference><Citation>Grozio A., Mills K.F., Yoshino J., Bruzzone S., Sociali G., Tokizane K., Lei H.C., Cunningham R., Sasaki Y., Migaud M.E., et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat. Metab. 2019;1:47&#x2013;57. doi: 10.1038/s42255-018-0009-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-018-0009-4</ArticleId><ArticleId IdType="pmc">PMC6530925</ArticleId><ArticleId IdType="pubmed">31131364</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Liu Y., Chen P., Shi X., Liu Y., Shi L., Cong P., Mao S., Tong C., Du C., et al. Solute carrier family 12 member 8 (SLC12A8) is a potential biomarker and related to tumor immune cell infiltration in bladder cancer. Bioengineered. 2021;12:4946&#x2013;4961. doi: 10.1080/21655979.2021.1962485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21655979.2021.1962485</ArticleId><ArticleId IdType="pmc">PMC8806707</ArticleId><ArticleId IdType="pubmed">34365894</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro C., Oyamada H.A.A., Cafasso M.O.S.D., Lopes L.M., Monteiro C., Sacramento P.M., Alves-Leon S.V., da Fontoura Galv&#xe3;o G., Hygino J., de Souza J.P.B.M., et al. Elevated proportion of TLR2- and TLR4-expressing Th17-like cells and activated memory B cells was associated with clinical activity of cerebral cavernous malformations. J. Neuroinflamm. 2022;19:28. doi: 10.1186/s12974-022-02385-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02385-2</ArticleId><ArticleId IdType="pmc">PMC8808981</ArticleId><ArticleId IdType="pubmed">35109870</ArticleId></ArticleIdList></Reference><Reference><Citation>Poltorak A., He X., Smirnova I., Liu M.-Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., et al. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene. Science. 1998;282:2085&#x2013;2088. doi: 10.1126/science.282.5396.2085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.282.5396.2085</ArticleId><ArticleId IdType="pubmed">9851930</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders H.-J. Toll-like receptors and danger signaling in kidney injury. J. Am. Soc. Nephrol. 2010;21:1270&#x2013;1274. doi: 10.1681/ASN.2010030233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2010030233</ArticleId><ArticleId IdType="pubmed">20651159</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt K.J., Fickentscher C., Kruithof E.K., de Moerloose P. TLR2 Ligands Induce NF-&#x3ba;B Activation from Endosomal Compartments of Human Monocytes. PLoS ONE. 2013;8:e80743. doi: 10.1371/journal.pone.0080743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080743</ArticleId><ArticleId IdType="pmc">PMC3861177</ArticleId><ArticleId IdType="pubmed">24349012</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell. 2011;147:868&#x2013;880. doi: 10.1016/j.cell.2011.09.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.09.051</ArticleId><ArticleId IdType="pmc">PMC3217211</ArticleId><ArticleId IdType="pubmed">22078883</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye H., Aune M.H., Stenvik J., Samstad E., Skjeldal F., Halaas O., Nilsen N.J., Stenmark H., Latz E., Lien E., et al. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity. 2010;33:583&#x2013;596. doi: 10.1016/j.immuni.2010.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.09.010</ArticleId><ArticleId IdType="pubmed">20933442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Lou J., Ouyang C., Chen W., Liu Y., Liu X., Cao X., Wang J., Lu L. Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane. Proc. Natl. Acad. Sci. USA. 2010;107:13806&#x2013;13811. doi: 10.1073/pnas.1009428107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009428107</ArticleId><ArticleId IdType="pmc">PMC2922283</ArticleId><ArticleId IdType="pubmed">20643919</ArticleId></ArticleIdList></Reference><Reference><Citation>Petnicki-Ocwieja T., Sharma B., Powale U., Pathak D., Tan S., Hu L.T. An AP-3-dependent pathway directs phagosome fusion with Rab8 and Rab11 vesicles involved in TLR2 signaling. Traffic. 2022;23:558&#x2013;567. doi: 10.1111/tra.12870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12870</ArticleId><ArticleId IdType="pubmed">36224049</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Liao J., Zhao M., Wu H., Yung S., Chan T.M., Yoshimura A., Lu Q. Increased expression of TLR2 in CD4+ T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications. Eur. J. Immunol. 2015;45:2683&#x2013;2693. doi: 10.1002/eji.201445219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201445219</ArticleId><ArticleId IdType="pubmed">26079624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyirenda M.H., Sanvito L., Darlington P.J., O&#x2019;Brien K., Zhang G.-X., Constantinescu C.S., Bar-Or A., Gran B. TLR2 Stimulation Drives Human Naive and Effector Regulatory T Cells into a Th17-Like Phenotype with Reduced Suppressive Function. J. Immunol. 2011;187:2278&#x2013;2290. doi: 10.4049/jimmunol.1003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003715</ArticleId><ArticleId IdType="pubmed">21775683</ArticleId></ArticleIdList></Reference><Reference><Citation>Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526&#x2013;1529. doi: 10.1126/science.1093620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1093620</ArticleId><ArticleId IdType="pubmed">14976262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.H., Choi S.J., Ji J.D., Song G.G. Association between toll-like receptor polymorphisms and systemic lupus erythematosus: A meta-analysis update. Lupus. 2016;25:593&#x2013;601. doi: 10.1177/0961203315622823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315622823</ArticleId><ArticleId IdType="pubmed">26762473</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.-M., Chang S.-W., Wu Y.-J.J., Lin J.-C., Ho H.-H., Chou T.-C., Yang B., Wu J., Chen J.-Y. Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population. Sci. Rep. 2014;4:3792. doi: 10.1038/srep03792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep03792</ArticleId><ArticleId IdType="pmc">PMC3896912</ArticleId><ArticleId IdType="pubmed">24445780</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Chai Q., Zhao Y., Li P., Qiao J., Huang J. Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosus. Int. J. Clin. Exp. Med. 2015;8:20472&#x2013;20480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4723808</ArticleId><ArticleId IdType="pubmed">26884963</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Villar M., Gautron A.-S., de Marcken M., Keller M.J., Hafler D.A. TLR7 induces anergy in human CD4+ T cells. Nat. Immunol. 2015;16:118&#x2013;128. doi: 10.1038/ni.3036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3036</ArticleId><ArticleId IdType="pmc">PMC4413902</ArticleId><ArticleId IdType="pubmed">25401424</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Liu X., Sanders K.L., Edwards J.L., Ye J., Si F., Gao A., Huang L., Hsueh E.C., Ford D.A., et al. TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy. Cell Metab. 2019;29:103&#x2013;123. doi: 10.1016/j.cmet.2018.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.09.020</ArticleId><ArticleId IdType="pmc">PMC7050437</ArticleId><ArticleId IdType="pubmed">30344014</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedrich C.M. Epigenetics in SLE. Curr. Rheumatol. Rep. 2017;19:58. doi: 10.1007/s11926-017-0685-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0685-1</ArticleId><ArticleId IdType="pmc">PMC5532407</ArticleId><ArticleId IdType="pubmed">28752494</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcocer-Varela J., Alarc&#xf3;n-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J. Clin. Investig. 1982;69:1388&#x2013;1392. doi: 10.1172/JCI110579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI110579</ArticleId><ArticleId IdType="pmc">PMC370212</ArticleId><ArticleId IdType="pubmed">6979554</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu S., Zhang N., Yopp A.C., Chen D., Mao M., Chen D., Zhang H., Ding Y., Bromberg J.S. TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25&#x2014;Precursors. Am. J. Transplant. 2004;4:1614&#x2013;1627. doi: 10.1111/j.1600-6143.2004.00566.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2004.00566.x</ArticleId><ArticleId IdType="pubmed">15367216</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek T.R., Yu A., Vincek V., Scibelli P., Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity. 2002;17:167&#x2013;178. doi: 10.1016/S1074-7613(02)00367-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(02)00367-9</ArticleId><ArticleId IdType="pubmed">12196288</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomou E.E., Juang Y.T., Gourley M.F., Kammer G.M., Tsokos G.C. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol. 2001;166:4216&#x2013;4222. doi: 10.4049/jimmunol.166.6.4216.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.166.6.4216</ArticleId><ArticleId IdType="pubmed">11238674</ArticleId></ArticleIdList></Reference><Reference><Citation>Juang Y.-T., Wang Y., Solomou E.E., Li Y., Mawrin C., Tenbrock K., Kyttaris V.C., Tsokos G.C. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Investig. 2005;115:996&#x2013;1005. doi: 10.1172/JCI22854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI22854</ArticleId><ArticleId IdType="pmc">PMC1070410</ArticleId><ArticleId IdType="pubmed">15841182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunahori K., Juang Y.-T., Kyttaris V.C., Tsokos G.C. Promoter Hypomethylation Results in Increased Expression of Protein Phosphatase 2A in T Cells from Patients with Systemic Lupus Erythematosus. J. Immunol. 2011;186:4508&#x2013;4517. doi: 10.4049/jimmunol.1000340.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1000340</ArticleId><ArticleId IdType="pmc">PMC3148941</ArticleId><ArticleId IdType="pubmed">21346232</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson K.A., Noeldner P.K., Reece K., Wadzinski B.E., Means A.R. Regulation and function of the calcium/calmodulin-dependent protein kinase IV/protein serine/threonine phosphatase 2A signaling complex. J. Biol. Chem. 2004;279:31708&#x2013;31716. doi: 10.1074/jbc.M404523200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M404523200</ArticleId><ArticleId IdType="pubmed">15143065</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsiari C.G., Kyttaris V.C., Juang Y.-T., Tsokos G.C. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J. Clin. Investig. 2005;115:3193&#x2013;3204. doi: 10.1172/JCI24895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI24895</ArticleId><ArticleId IdType="pmc">PMC1253625</ArticleId><ArticleId IdType="pubmed">16224536</ArticleId></ArticleIdList></Reference><Reference><Citation>Juang Y.-T., Rauen T., Wang Y., Ichinose K., Benedyk K., Tenbrock K., Tsokos G.C. Transcriptional Activation of the cAMP-responsive Modulator Promoter in Human T Cells Is Regulated by Protein Phosphatase 2A-mediated Dephosphorylation of SP-1 and Reflects Disease Activity in Patients with Systemic Lupus Erythematosus. J. Biol. Chem. 2011;286:1795&#x2013;1801. doi: 10.1074/jbc.M110.166785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.166785</ArticleId><ArticleId IdType="pmc">PMC3023474</ArticleId><ArticleId IdType="pubmed">21097497</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassilopoulos D., Kovacs B., Tsokos G.C. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol. 1995;155:2269&#x2013;2281. doi: 10.4049/jimmunol.155.4.2269.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.155.4.2269</ArticleId><ArticleId IdType="pubmed">7636273</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton V.R., Tsokos G.C. Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res. 2011;13:207. doi: 10.1186/ar3251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3251</ArticleId><ArticleId IdType="pmc">PMC3132009</ArticleId><ArticleId IdType="pubmed">21457530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyttaris V.C., Wang Y., Juang Y.-T., Weinstein A., Tsokos G.C. Increased Levels of NF-ATc2 Differentially Regulate CD154 and IL-2 Genes in T Cells from Patients with Systemic Lupus Erythematosus. J. Immunol. 2007;178:1960&#x2013;1966. doi: 10.4049/jimmunol.178.3.1960.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.178.3.1960</ArticleId><ArticleId IdType="pubmed">17237447</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 1997;9:240&#x2013;246. doi: 10.1016/S0955-0674(97)80068-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0955-0674(97)80068-3</ArticleId><ArticleId IdType="pubmed">9069263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyttaris V.C., Juang Y.-T., Tenbrock K., Weinstein A., Tsokos G.C. Cyclic adenosine 5&#x2032;-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus. J. Immunol. 2004;173:3557&#x2013;3563. doi: 10.4049/jimmunol.173.5.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.173.5.3557</ArticleId><ArticleId IdType="pubmed">15322221</ArticleId></ArticleIdList></Reference><Reference><Citation>Foulkes N.S., Laoide B.M., Schlotter F., Sassone-Corsi P. Transcriptional antagonist cAMP-responsive element modulator (CREM) down-regulates c-fos cAMP-induced expression. Proc. Natl. Acad. Sci. USA. 1991;88:5448&#x2013;5452. doi: 10.1073/pnas.88.12.5448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.12.5448</ArticleId><ArticleId IdType="pmc">PMC51890</ArticleId><ArticleId IdType="pubmed">1647033</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenbrock K., Tsokos G.C. Transcriptional Regulation of Interlekin 2 in Sle T Cells. Int. Rev. Immunol. 2004;23:333&#x2013;345. doi: 10.1080/08830180490452558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08830180490452558</ArticleId><ArticleId IdType="pubmed">15204092</ArticleId></ArticleIdList></Reference><Reference><Citation>Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell. 2005;16:4623&#x2013;4635. doi: 10.1091/mbc.e05-01-0033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e05-01-0033</ArticleId><ArticleId IdType="pmc">PMC1237069</ArticleId><ArticleId IdType="pubmed">16079181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hisada R., Yoshida N., Umeda M., Burbano C., Bhargava R., Scherlinger M., Kono M., Kyttaris V.C., Krishfield S., Tsokos G.C. The deacetylase SIRT2 contributes to autoimmune disease pathogenesis by modulating IL-17A and IL-2 transcription. Cell Mol. Immunol. 2022;19:738&#x2013;750. doi: 10.1038/s41423-022-00874-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-022-00874-1</ArticleId><ArticleId IdType="pmc">PMC9151795</ArticleId><ArticleId IdType="pubmed">35523941</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg V., Modak M., Brell J., Puck A., K&#xfc;nig S., Jutz S., Steinberger P., Zlabinger G.J., St&#xf6;ckl J. Iron Deprivation in Human T Cells Induces Nonproliferating Accessory Helper Cells. ImmunoHorizons. 2020;4:165&#x2013;177. doi: 10.4049/immunohorizons.2000003.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2000003</ArticleId><ArticleId IdType="pubmed">32284314</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Zhou X., Cui D., Zhang W., Lai J., Li X., Ruan Y., Xie Y., Shi M., Xiao Y., et al. The role of Stim1 in the progression of lupus nephritis in mice. Int. J. Clin. Exp. Pathol. 2020;13:3021&#x2013;3032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7791395</ArticleId><ArticleId IdType="pubmed">33425103</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Zhao Q., Ke C., Long S., Zhang F., Zhang X., Li Y., Liu X., Hu H., Yin S. Loureirin B Exerts its Immunosuppressive Effects by Inhibiting STIM1/Orai1 and KV1.3 Channels. Front. Pharmacol. 2021;12:685092. doi: 10.3389/fphar.2021.685092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.685092</ArticleId><ArticleId IdType="pmc">PMC8268022</ArticleId><ArticleId IdType="pubmed">34248635</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambiar M.P., Fisher C.U., Warke V.G., Krishnan S., Mitchell J.P., Delaney N., Tsokos G.C. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum. 2003;48:1948&#x2013;1955. doi: 10.1002/art.11072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11072</ArticleId><ArticleId IdType="pubmed">12847689</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada T., Kyttaris V., Li Y., Juang Y.-T., Wang Y., Tsokos G.C. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity. 2007;40:1&#x2013;8. doi: 10.1080/08916930601095148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930601095148</ArticleId><ArticleId IdType="pubmed">17364491</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007;26:371&#x2013;381. doi: 10.1016/j.immuni.2007.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.02.009</ArticleId><ArticleId IdType="pubmed">17363300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C.K., Ho C.Y., Li E.K., Lam C.W. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus. 2000;9:589&#x2013;593. doi: 10.1191/096120300678828703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/096120300678828703</ArticleId><ArticleId IdType="pubmed">11035433</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp&#xed;n J.C., Oukka M., Bayliss G., Cohen R.A., Van Beek C.A., Stillman I.E., Kyttaris V.C., Juang Y.-T., Tsokos G.C. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 2008;181:8761&#x2013;8766. doi: 10.4049/jimmunol.181.12.8761.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.12.8761</ArticleId><ArticleId IdType="pmc">PMC2596652</ArticleId><ArticleId IdType="pubmed">19050297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah K., Lee W.-W., Lee S.-H., Kim S.H., Kang S.W., Craft J., Kang I. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res. 2010;12:R53. doi: 10.1186/ar2964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2964</ArticleId><ArticleId IdType="pmc">PMC2888202</ArticleId><ArticleId IdType="pubmed">20334681</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Chu Y., Yang X., Gao D., Zhu L., Yang X., Wan L., Li M. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 2009;60:1472&#x2013;1483. doi: 10.1002/art.24499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24499</ArticleId><ArticleId IdType="pubmed">19404966</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzenberger P., La Russa V., Miller A., Ye P., Huang W., Zieske A., Nelson S., Bagby G.J., Stoltz D., Mynatt R.L., et al. IL-17 stimulates granulopoiesis in mice: Use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 1998;161:6383&#x2013;6389. doi: 10.4049/jimmunol.161.11.6383.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.161.11.6383</ArticleId><ArticleId IdType="pubmed">9834129</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzenberger P., Huang W., Ye P., Oliver P., Manuel M., Zhang Z., Bagby G., Nelson S., Kolls J.K. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 2000;164:4783&#x2013;4789. doi: 10.4049/jimmunol.164.9.4783.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.9.4783</ArticleId><ArticleId IdType="pubmed">10779785</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzenberger P., Huang W., Oliver P., Byrne P., La Russa V., Zhang Z., Kolls J.K. IL-17 Mobilizes Peripheral Blood Stem Cells with Short- and Long-Term Repopulating Ability in Mice. J. Immunol. 2001;167:2081&#x2013;2086. doi: 10.4049/jimmunol.167.4.2081.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.167.4.2081</ArticleId><ArticleId IdType="pubmed">11489991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W., Huang W., Zhong Q., Schwarzenberger P. IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation. J. Immunol. 2006;176:6186&#x2013;6193. doi: 10.4049/jimmunol.176.10.6186.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.10.6186</ArticleId><ArticleId IdType="pubmed">16670328</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Vietinghoff S., Ley K. IL-17A Controls IL-17F Production and Maintains Blood Neutrophil Counts in Mice. J. Immunol. 2009;183:865&#x2013;873. doi: 10.4049/jimmunol.0804080.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0804080</ArticleId><ArticleId IdType="pmc">PMC2759196</ArticleId><ArticleId IdType="pubmed">19542376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsdoerffer M., Lee Y., J&#xe4;ger A., Kim H.-J., Korn T., Kolls J.K., Cantor H., Bettelli E., Kuchroo V.K. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. USA. 2010;107:14292&#x2013;14297. doi: 10.1073/pnas.1009234107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1009234107</ArticleId><ArticleId IdType="pmc">PMC2922571</ArticleId><ArticleId IdType="pubmed">20660725</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp&#xed;n J.C., Liossis S.-N.C., Kis-Toth K., Lieberman L.A., Kyttaris V.C., Juang Y.-T., Tsokos G.C. Pathogenesis of human systemic lupus erythematosus: Recent advances. Trends Mol. Med. 2010;16:47&#x2013;57. doi: 10.1016/j.molmed.2009.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2009.12.005</ArticleId><ArticleId IdType="pmc">PMC2823952</ArticleId><ArticleId IdType="pubmed">20138006</ArticleId></ArticleIdList></Reference><Reference><Citation>Riol-Blanco L., Lazarevic V., Awasthi A., Mitsdoerffer M., Wilson B.S., Croxford A., Waisman A., Kuchroo V.K., Glimcher L.H., Oukka M. IL-23 Receptor Regulates Unconventional IL-17&#x2013;Producing T Cells That Control Bacterial Infections. J. Immunol. 2010;184:1710&#x2013;1720. doi: 10.4049/jimmunol.0902796.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902796</ArticleId><ArticleId IdType="pmc">PMC2829977</ArticleId><ArticleId IdType="pubmed">20083652</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.-H., Wang Y., Hood L., Zhu Z., Tian Q., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005;6:1133&#x2013;1141. doi: 10.1038/ni1261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1261</ArticleId><ArticleId IdType="pmc">PMC1618871</ArticleId><ArticleId IdType="pubmed">16200068</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17&#x2013;producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005;6:1123&#x2013;1132. doi: 10.1038/ni1254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1254</ArticleId><ArticleId IdType="pubmed">16200070</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp&#xed;n J.C., Tsokos G.C. Human TCR-&#x3b1;&#x3b2;+ CD4&#x2212; CD8&#x2212; T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype. J. Immunol. 2009;183:4675&#x2013;4681. doi: 10.4049/jimmunol.0901533.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901533</ArticleId><ArticleId IdType="pmc">PMC2878279</ArticleId><ArticleId IdType="pubmed">19734235</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos G.C. Systemic Lupus Erythematosus. N. Engl. J. Med. 2011;365:2110&#x2013;2121. doi: 10.1056/NEJMra1100359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1100359</ArticleId><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangan P.R., Harrington L.E., O&#x2019;Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-&#x3b2; induces development of the TH17 lineage. Nature. 2006;441:231&#x2013;234. doi: 10.1038/nature04754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04754</ArticleId><ArticleId IdType="pubmed">16648837</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., Kuchroo V.K., Hafler D.A. IL-21 and TGF-&#x3b2; are required for differentiation of human TH17 cells. Nature. 2008;454:350&#x2013;352. doi: 10.1038/nature07021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07021</ArticleId><ArticleId IdType="pmc">PMC2760130</ArticleId><ArticleId IdType="pubmed">18469800</ArticleId></ArticleIdList></Reference><Reference><Citation>Iezzi G., Sonderegger I., Ampenberger F., Schmitz N., Marsland B.J., Kopf M. CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc. Natl. Acad. Sci. USA. 2009;106:876&#x2013;881. doi: 10.1073/pnas.0810769106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810769106</ArticleId><ArticleId IdType="pmc">PMC2630101</ArticleId><ArticleId IdType="pubmed">19136631</ArticleId></ArticleIdList></Reference><Reference><Citation>Javierre B.M., Richardson B. A new epigenetic challenge: Systemic lupus erythematosus. Adv. Exp. Med. Biol. 2011;711:117&#x2013;136. doi: 10.1007/978-1-4419-8216-2_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4419-8216-2_9</ArticleId><ArticleId IdType="pubmed">21627046</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghodke-Puranik Y., Niewold T.B. Immunogenetics of systemic lupus erythematosus: A comprehensive review. J. Autoimmun. 2015;64:125&#x2013;136. doi: 10.1016/j.jaut.2015.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.08.004</ArticleId><ArticleId IdType="pmc">PMC4628859</ArticleId><ArticleId IdType="pubmed">26324017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T. Interleukin 6 and its Receptor: Ten Years Later. Int. Rev. Immunol. 1998;16:249&#x2013;284. doi: 10.3109/08830189809042997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830189809042997</ArticleId><ArticleId IdType="pubmed">9505191</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbour S.N., DiToro D.F., Witte S.J., Zindl C.L., Gao M., Schoeb T.R., Jones G.W., Jones S.A., Hatton R.D., Weaver C.T. TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci. Immunol. 2020;5:eaaw2262. doi: 10.1126/sciimmunol.aaw2262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aaw2262</ArticleId><ArticleId IdType="pmc">PMC7843024</ArticleId><ArticleId IdType="pubmed">32680955</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalaris A., Garbers C., Rabe B., Rose-John S., Scheller J. The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer. Eur. J. Cell Biol. 2011;90:484&#x2013;494. doi: 10.1016/j.ejcb.2010.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2010.10.007</ArticleId><ArticleId IdType="pubmed">21145125</ArticleId></ArticleIdList></Reference><Reference><Citation>La Belle Flynn A., Calhoun B.C., Sharma A., Chang J.C., Almasan A., Schiemann W.P. Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression. Nat. Commun. 2019;10:3668. doi: 10.1038/s41467-019-11640-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11640-9</ArticleId><ArticleId IdType="pmc">PMC6694140</ArticleId><ArticleId IdType="pubmed">31413316</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson D.E., O&#x2019;Keefe R.A., Grandis J.R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 2018;15:234&#x2013;248. doi: 10.1038/nrclinonc.2018.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrclinonc.2018.8</ArticleId><ArticleId IdType="pmc">PMC5858971</ArticleId><ArticleId IdType="pubmed">29405201</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimica V., Chen H.-C., Iyer J.K., Reich N.C. Dynamics of the STAT3 transcription factor: Nuclear import dependent on Ran and importin-&#x3b2;1. PLoS ONE. 2011;6:e20188. doi: 10.1371/journal.pone.0020188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020188</ArticleId><ArticleId IdType="pmc">PMC3098288</ArticleId><ArticleId IdType="pubmed">21625522</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., Littman D.R. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007;8:967&#x2013;974. doi: 10.1038/ni1488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1488</ArticleId><ArticleId IdType="pubmed">17581537</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeachy M.J., Chen Y., Tato C.M., Laurence A., Joyce-Shaikh B., Blumenschein W.M., McClanahan T.K., O&#x2019;Shea J.J., Cua D.J. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 2009;10:314&#x2013;324. doi: 10.1038/ni.1698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1698</ArticleId><ArticleId IdType="pmc">PMC2945605</ArticleId><ArticleId IdType="pubmed">19182808</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga T., Hedrich C.M., Mizui M., Yoshida N., Otomo K., Lieberman L.A., Rauen T., Crisp&#xed;n J.C., Tsokos G.C. CaMK4-dependent activation of AKT/mTOR and CREM-&#x3b1; underlies autoimmunity-associated Th17 imbalance. J. Clin. Investig. 2014;124:2234&#x2013;2245. doi: 10.1172/JCI73411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI73411</ArticleId><ArticleId IdType="pmc">PMC4001553</ArticleId><ArticleId IdType="pubmed">24667640</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama T., Tsokos G.C., Moulton V.R. Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus. Front. Immunol. 2018;9:1088. doi: 10.3389/fimmu.2018.01088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01088</ArticleId><ArticleId IdType="pmc">PMC5967272</ArticleId><ArticleId IdType="pubmed">29868033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedrich C.M., Crispin J.C., Rauen T., Ioannidis C., Apostolidis S.A., Lo M.S., Kyttaris V.C., Tsokos G.C. cAMP response element modulator &#x3b1; controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc. Natl. Acad. Sci. USA. 2012;109:16606&#x2013;16611. doi: 10.1073/pnas.1210129109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1210129109</ArticleId><ArticleId IdType="pmc">PMC3478624</ArticleId><ArticleId IdType="pubmed">23019580</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson B. Primer: Epigenetics of autoimmunity. Nat. Clin. Pract. Rheumatol. 2007;3:521&#x2013;527. doi: 10.1038/ncprheum0573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncprheum0573</ArticleId><ArticleId IdType="pubmed">17762851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrey C.L., Liu L., Andrews L.G., Tollefsbol T.O. The impact of metabolism on DNA methylation. Hum. Mol. Genet. 2005;14:R139&#x2013;R147. doi: 10.1093/hmg/ddi100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddi100</ArticleId><ArticleId IdType="pubmed">15809266</ArticleId></ArticleIdList></Reference><Reference><Citation>Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell. 2012;149:274&#x2013;293. doi: 10.1016/j.cell.2012.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.017</ArticleId><ArticleId IdType="pmc">PMC3331679</ArticleId><ArticleId IdType="pubmed">22500797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoncu R., Efeyan A., Sabatini D.M. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 2011;12:21&#x2013;35. doi: 10.1038/nrm3025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3025</ArticleId><ArticleId IdType="pmc">PMC3390257</ArticleId><ArticleId IdType="pubmed">21157483</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307:1098&#x2013;1101. doi: 10.1126/science.1106148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1106148</ArticleId><ArticleId IdType="pubmed">15718470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurebayashi Y., Nagai S., Ikejiri A., Ohtani M., Ichiyama K., Baba Y., Yamada T., Egami S., Hoshii T., Hirao A., et al. PI3K-Akt-mTORC1-S6K1/2 Axis Controls Th17 Differentiation by Regulating Gfi1 Expression and Nuclear Translocation of ROR&#x3b3;. Cell Rep. 2012;1:360&#x2013;373. doi: 10.1016/j.celrep.2012.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.02.007</ArticleId><ArticleId IdType="pubmed">22832227</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgoffe G.M., Pollizzi K.N., Waickman A.T., Heikamp E., Meyers D.J., Horton M.R., Xiao B., Worley P.F., Powell J.D. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 2011;12:295&#x2013;303. doi: 10.1038/ni.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2005</ArticleId><ArticleId IdType="pmc">PMC3077821</ArticleId><ArticleId IdType="pubmed">21358638</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair L.V., Rolf J., Emslie E., Shi Y.-B., Taylor P.M., Cantrell D.A. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat. Immunol. 2013;14:500&#x2013;508. doi: 10.1038/ni.2556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2556</ArticleId><ArticleId IdType="pmc">PMC3672957</ArticleId><ArticleId IdType="pubmed">23525088</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez D., Bonilla E., Mirza N., Niland B., Perl A. Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthiritis Rhem. 2006;54:2983&#x2013;2988. doi: 10.1002/art.22085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22085</ArticleId><ArticleId IdType="pmc">PMC4034146</ArticleId><ArticleId IdType="pubmed">16947529</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu Y., Zhao C., Zhang B., Wang X., Wang Y., An J., Chen J. Restoring T-helper 17 cell/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus. Lupus. 2019;28:1397&#x2013;1406. doi: 10.1177/0961203319877239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319877239</ArticleId><ArticleId IdType="pubmed">31551029</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R. Central role of PI3K&#x2013;SYK interaction in fibrinogen-induced lamellipodia and filopodia formation in platelets. FEBS Open. Bio. 2016;6:1285&#x2013;1296. doi: 10.1002/2211-5463.12149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.12149</ArticleId><ArticleId IdType="pmc">PMC5324771</ArticleId><ArticleId IdType="pubmed">28255536</ArticleId></ArticleIdList></Reference><Reference><Citation>Simioni C., Martelli A.M., Zauli G., Vitale M., McCubrey J.A., Capitani S., Neri L.M. Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update. J. Cell. Physiol. 2018;233:6440&#x2013;6454. doi: 10.1002/jcp.26539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26539</ArticleId><ArticleId IdType="pubmed">29667769</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymonowicz K., Oeck S., Malewicz N.M., Jendrossek V. New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response. Cancers. 2018;10:78. doi: 10.3390/cancers10030078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers10030078</ArticleId><ArticleId IdType="pmc">PMC5876653</ArticleId><ArticleId IdType="pubmed">29562639</ArticleId></ArticleIdList></Reference><Reference><Citation>Henske E.P., J&#xf3;&#x17a;wiak S., Kingswood J.C., Sampson J.R., Thiele E.A. Tuberous sclerosis complex. Nat. Rev. Dis. Prim. 2016;2:16035. doi: 10.1038/nrdp.2016.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.35</ArticleId><ArticleId IdType="pubmed">27226234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H., Perl A. Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4&#x2212; CD8&#x2212; Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus. J. Immunol. 2014;192:4134&#x2013;4144. doi: 10.4049/jimmunol.1301859.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301859</ArticleId><ArticleId IdType="pmc">PMC3995867</ArticleId><ArticleId IdType="pubmed">24683191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926&#x2013;1945. doi: 10.1101/gad.1212704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1212704</ArticleId><ArticleId IdType="pubmed">15314020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridharan S., Basu A. Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer. Int. J. Mol. Sci. 2020;21:1199. doi: 10.3390/ijms21041199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041199</ArticleId><ArticleId IdType="pmc">PMC7072743</ArticleId><ArticleId IdType="pubmed">32054043</ArticleId></ArticleIdList></Reference><Reference><Citation>GFI1 Growth Factor Independent 1 Transcriptional Repressor [Homo Sapiens (Human)]&#x2014;Gene&#x2014;NCBI.  [(accessed on 1 June 2021)]; Available online:  https://www.ncbi.nlm.nih.gov/gene/2672.</Citation></Reference><Reference><Citation>Ichiyama K., Hashimoto M., Sekiya T., Nakagawa R., Wakabayashi Y., Sugiyama Y., Komai K., Saba I., Moroy T., Yoshimura A. Gfi1 negatively regulates Th17 differentiation by inhibiting ROR t activity. Int. Immunol. 2009;21:881&#x2013;889. doi: 10.1093/intimm/dxp054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxp054</ArticleId><ArticleId IdType="pubmed">19505891</ArticleId></ArticleIdList></Reference><Reference><Citation>EGR2 Early Growth Response 2 [Homo Sapiens (Human)]&#x2014;Gene&#x2014;NCBI.  [(accessed on 1 June 2021)]; Available online:  https://www.ncbi.nlm.nih.gov/gene/1959.</Citation></Reference><Reference><Citation>Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121&#x2013;1133. doi: 10.1016/j.cell.2006.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.07.035</ArticleId><ArticleId IdType="pubmed">16990136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono M. New insights into the metabolism of Th17 cells. Immunol. Med. 2022;46:15&#x2013;24. doi: 10.1080/25785826.2022.2140503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/25785826.2022.2140503</ArticleId><ArticleId IdType="pubmed">36326754</ArticleId></ArticleIdList></Reference><Reference><Citation>Damasceno L.E.A., Prado D.S., Veras F.P., Fonseca M.M., Toller-Kawahisa J.E., Rosa M.H., P&#xfa;blio G.A., Martins T.V., Ramalho F.S., Waisman A., et al. PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation. J. Exp. Med. 2020;217:e20190613. doi: 10.1084/jem.20190613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190613</ArticleId><ArticleId IdType="pmc">PMC7537396</ArticleId><ArticleId IdType="pubmed">32697823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono M., Maeda K., Stocton-Gavanescu I., Pan W., Umeda M., Katsuyama E., Burbano C., Orite S.Y.K., Vukelic M., Tsokos M.G., et al. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation. JCI Insight. 2019;4:e127395. doi: 10.1172/jci.insight.127395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.127395</ArticleId><ArticleId IdType="pmc">PMC6629104</ArticleId><ArticleId IdType="pubmed">31217348</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida N., Comte D., Mizui M., Otomo K., Rosetti F., Mayadas T.N., Crisp&#xed;n J.C., Bradley S.J., Koga T., Kono M., et al. ICER is requisite for Th17 differentiation. Nat. Commun. 2016;7:12993. doi: 10.1038/ncomms12993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12993</ArticleId><ArticleId IdType="pmc">PMC5056420</ArticleId><ArticleId IdType="pubmed">27680869</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang E.V., Barbi J., Yang H.-Y., Jinasena D., Yu H., Zheng Y., Bordman Z., Fu J., Kim Y., Yen H.-R., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146:772&#x2013;784. doi: 10.1016/j.cell.2011.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.07.033</ArticleId><ArticleId IdType="pmc">PMC3387678</ArticleId><ArticleId IdType="pubmed">21871655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3:177&#x2013;185. doi: 10.1016/j.cmet.2006.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2006.02.002</ArticleId><ArticleId IdType="pubmed">16517405</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Ma Y., Cole S.M., Zander C., Chen K.-H., Karras J., Pope R.M. Serine phosphorylation of STAT3 is essential for Mcl-1 expression and macrophage survival. Blood. 2003;102:344&#x2013;352. doi: 10.1182/blood-2002-11-3396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-11-3396</ArticleId><ArticleId IdType="pubmed">12637318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cal&#xf2; V., Migliavacca M., Bazan V., Macaluso M., Buscemi M., Gebbia N., Russo A. STAT proteins: From normal control of cellular events to tumorigenesis. J. Cell Physiol. 2003;197:157&#x2013;168. doi: 10.1002/jcp.10364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.10364</ArticleId><ArticleId IdType="pubmed">14502555</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Z., Zhong Z., Darnell J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995;82:241&#x2013;250. doi: 10.1016/0092-8674(95)90311-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90311-9</ArticleId><ArticleId IdType="pubmed">7543024</ArticleId></ArticleIdList></Reference><Reference><Citation>Decker T., Kovarik P. Serine phosphorylation of STATs. Oncogene. 2000;19:2628&#x2013;2637. doi: 10.1038/sj.onc.1203481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1203481</ArticleId><ArticleId IdType="pubmed">10851062</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-H., Yoon M.-S., Chen J. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation. J. Biol. Chem. 2009;284:35425&#x2013;35432. doi: 10.1074/jbc.M109.051516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.051516</ArticleId><ArticleId IdType="pmc">PMC2790971</ArticleId><ArticleId IdType="pubmed">19875458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kshirsagar S., Riedl M., Billing H., T&#xf6;nshoff B., Thangavadivel S., Steuber C., Staude H., Wechselberger G., Edelbauer M. Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis. J. Immunol. 2014;193:4895&#x2013;4903. doi: 10.4049/jimmunol.1400044.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400044</ArticleId><ArticleId IdType="pubmed">25339666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sequeira J., Boily G., Bazinet S., Saliba S., He X., Jardine K., Kennedy C., Staines W., Rousseaux C., Mueller R., et al. sirt1-null mice develop an autoimmune-like condition. Exp. Cell Res. 2008;314:3069&#x2013;3074. doi: 10.1016/j.yexcr.2008.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2008.07.011</ArticleId><ArticleId IdType="pubmed">18687325</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie Y., Erion D.M., Yuan Z., Dietrich M., Shulman G.I., Horvath T.L., Gao Q. STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat. Cell Biol. 2009;11:492&#x2013;500. doi: 10.1038/ncb1857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1857</ArticleId><ArticleId IdType="pmc">PMC2790597</ArticleId><ArticleId IdType="pubmed">19295512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z., Guan Y., Chatterjee D., Chin Y.E. Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue. Science. 2005;307:269&#x2013;273. doi: 10.1126/science.1105166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1105166</ArticleId><ArticleId IdType="pubmed">15653507</ArticleId></ArticleIdList></Reference><Reference><Citation>Limagne E., Thibaudin M., Euvrard R., Berger H., Chalons P., V&#xe9;gan F., Humblin E., Boidot R., R&#xe9;b&#xe9; C., Derang&#xe8;re V., et al. Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation. Cell Rep. 2017;19:746&#x2013;759. doi: 10.1016/j.celrep.2017.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.04.004</ArticleId><ArticleId IdType="pubmed">28445726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Hu Y., Yang C., Zhu S., Wang X., Zhang Z., Deng H. Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition. Mol. Cell. Proteom. 2018;17:2005&#x2013;2017. doi: 10.1074/mcp.RA118.000882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.RA118.000882</ArticleId><ArticleId IdType="pmc">PMC6166677</ArticleId><ArticleId IdType="pubmed">29980616</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Alvarez B., Rodriguez R.M., Fraga M.F., L&#xf3;pez-Larrea C. DNA methylation: A promising landscape for immune system-related diseases. Trends Genet. 2012;28:506&#x2013;514. doi: 10.1016/j.tig.2012.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2012.06.005</ArticleId><ArticleId IdType="pubmed">22824525</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsagaratou A., Lio C.-W.J., Yue X., Rao A. TET Methylcytosine Oxidases in T Cell and B Cell Development and Function. Front. Immunol. 2017;8:220. doi: 10.3389/fimmu.2017.00220.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00220</ArticleId><ArticleId IdType="pmc">PMC5374156</ArticleId><ArticleId IdType="pubmed">28408905</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballestar E., Sawalha A.H., Lu Q. Clinical value of DNA methylation markers in autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 2020;16:514&#x2013;524. doi: 10.1038/s41584-020-0470-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0470-9</ArticleId><ArticleId IdType="pmc">PMC7955859</ArticleId><ArticleId IdType="pubmed">32759997</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunahori K., Nagpal K., Hedrich C.M., Mizui M., Fitzgerald L.M., Tsokos G.C. The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients. J. Biol. Chem. 2013;288:21936&#x2013;21944. doi: 10.1074/jbc.M113.467266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.467266</ArticleId><ArticleId IdType="pmc">PMC3724648</ArticleId><ArticleId IdType="pubmed">23775084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamanaha E., Guan S., Marks K., Saleh L. Distributive Processing by the Iron(II)/&#x3b1;-Ketoglutarate-Dependent Catalytic Domains of the TET Enzymes Is Consistent with Epigenetic Roles for Oxidized 5-Methylcytosine Bases. J. Am. Chem. Soc. 2016;138:9345&#x2013;9348. doi: 10.1021/jacs.6b03243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.6b03243</ArticleId><ArticleId IdType="pubmed">27362828</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly P.M., Parton H., Wang L., McCune W.J., Lim S.S., Drenkard C., Ferucci E.D., Dall&#x2019;Era M., Gordon C., Helmick C.G., et al. Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Registries. Arthritis Rheumatol. 2021;73:991&#x2013;996. doi: 10.1002/art.41632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41632</ArticleId><ArticleId IdType="pmc">PMC8169527</ArticleId><ArticleId IdType="pubmed">33474834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes T., Adler A., Merrill J.T., Kelly J.A., Kaufman K.M., Williams A., Langefeld C.D., Gilkeson G.S., Sanchez E., Martin J., et al. Analysis of autosomal genes reveals gene&#x2013;sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Ann. Rheum. Dis. 2012;71:694&#x2013;699. doi: 10.1136/annrheumdis-2011-200385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2011-200385</ArticleId><ArticleId IdType="pmc">PMC3324666</ArticleId><ArticleId IdType="pubmed">22110124</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawalha A.H., Wang L., Nadig A., Somers E.C., McCune W.J., Michigan Lupus Cohort. Hughes T., Merrill J.T., Scofield R.H., Strickland F.M., et al. Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J. Autoimmun. 2012;38:J216&#x2013;J222. doi: 10.1016/j.jaut.2011.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2011.11.008</ArticleId><ArticleId IdType="pmc">PMC3313010</ArticleId><ArticleId IdType="pubmed">22305513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali M., Coit P., Sawalha A.H. Sex-based comparison of CD4+ T cell DNA methylation in lupus reveals proinflammatory epigenetic changes in men. Clin. Immunol. 2022;243:109116. doi: 10.1016/j.clim.2022.109116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109116</ArticleId><ArticleId IdType="pmc">PMC10236946</ArticleId><ArticleId IdType="pubmed">36075396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao S., Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 2009;10:281&#x2013;288. doi: 10.1038/ni.1699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1699</ArticleId><ArticleId IdType="pmc">PMC2775040</ArticleId><ArticleId IdType="pubmed">19198593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafasla P., Skliris A., Kontoyiannis D.L. Post-transcriptional coordination of immunological responses by RNA-binding proteins. Nat. Immunol. 2014;15:492&#x2013;502. doi: 10.1038/ni.2884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2884</ArticleId><ArticleId IdType="pubmed">24840980</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothamel K., Arcos S., Kim B., Reasoner C., Lisy S., Mukherjee N., Ascano M. ELAVL1 primarily couples mRNA stability with the 3&#x2032; UTRs of interferon-stimulated genes. Cell Rep. 2021;35:109178. doi: 10.1016/j.celrep.2021.109178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109178</ArticleId><ArticleId IdType="pmc">PMC8225249</ArticleId><ArticleId IdType="pubmed">34038724</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini M., Magnani E., Macchi F., Bonapace I.M. The multi-functionality of UHRF1: Epigenome maintenance and preservation of genome integrity. Nucleic Acids Res. 2021;49:6053&#x2013;6068. doi: 10.1093/nar/gkab293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab293</ArticleId><ArticleId IdType="pmc">PMC8216287</ArticleId><ArticleId IdType="pubmed">33939809</ArticleId></ArticleIdList></Reference><Reference><Citation>Obata Y., Furusawa Y., Endo T.A., Sharif J., Takahashi D., Atarashi K., Nakayama M., Onawa S., Fujimura Y., Takahashi M., et al. The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells. Nat. Immunol. 2014;15:571&#x2013;579. doi: 10.1038/ni.2886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2886</ArticleId><ArticleId IdType="pubmed">24777532</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Hu L., Yang L., Jia S., Du P., Min X., Wu J., Wu H., Long H., Lu Q., et al. UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE. Clin. Epigenetics. 2021;13:31. doi: 10.1186/s13148-021-01007-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-021-01007-7</ArticleId><ArticleId IdType="pmc">PMC7874639</ArticleId><ArticleId IdType="pubmed">33568199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.K., Workman J.L. Histone acetyltransferase complexes: One size doesn&#x2019;t fit all. Nat. Rev. Mol. Cell Biol. 2007;8:284&#x2013;295. doi: 10.1038/nrm2145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2145</ArticleId><ArticleId IdType="pubmed">17380162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu N., Qiu X., Luo Y., Yuan J., Li Y., Lei W., Zhang G., Zhou Y., Su Y., Lu Q. Abnormal histone modification patterns in lupus CD4+ T cells. J. Rheumatol. 2008;35:804&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">18398941</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra N., Reilly C.M., Brown D.R., Ruiz P., Gilkeson G.S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Investig. 2003;111:539&#x2013;552. doi: 10.1172/JCI16153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI16153</ArticleId><ArticleId IdType="pmc">PMC151922</ArticleId><ArticleId IdType="pubmed">12588892</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu K.T., Kanno Y., Cannons J.L., Handon R., Bible P., Elkahloun A.G., Anderson S.M., Wei L., Sun H., O&#x2019;Shea J.J., et al. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity. 2011;35:622&#x2013;632. doi: 10.1016/j.immuni.2011.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.07.015</ArticleId><ArticleId IdType="pmc">PMC3235706</ArticleId><ArticleId IdType="pubmed">22018472</ArticleId></ArticleIdList></Reference><Reference><Citation>Poholek A.C., Hansen K., Hernandez S.G., Eto D., Chandele A., Weinstein J.S., Dong X., Odegard J.M., Kaech S.M., Dent A.L., et al. In vivo regulation of Bcl6 and T follicular helper cell development. J. Immunol. 2010;185:313&#x2013;326. doi: 10.4049/jimmunol.0904023.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0904023</ArticleId><ArticleId IdType="pmc">PMC2891136</ArticleId><ArticleId IdType="pubmed">20519643</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayamada S., Poholek A.C., Lu K.T., Takahashi H., Kato M., Iwata S., Hirahara K., Cannons J.L., Schwartzberg P.L., Vahedi G., et al. Type I Interferon induces binding of STAT1 to Bcl6: Divergent Roles of STAT-family transcription factors in the TFH cell genetic program. J. Immunol. 2014;192:2156&#x2013;2166. doi: 10.4049/jimmunol.1300675.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300675</ArticleId><ArticleId IdType="pmc">PMC3967131</ArticleId><ArticleId IdType="pubmed">24489092</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X., Antao O.Q., Song W., Sanchez G.M., Zembrzuski K., Koumpouras F., Lemenze A., Craft J., Weinstein J.S. Type 1 interferon activated STAT4 regulates T follicular helper (Tfh)-cell dependent cytokine and immunoglobulin production in lupus. Arthritis Rheumatol. 2021;73:478&#x2013;489. doi: 10.1002/art.41532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41532</ArticleId><ArticleId IdType="pmc">PMC7914134</ArticleId><ArticleId IdType="pubmed">33512094</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard E., Chmiest D., Fournier N., Johannes L., Paul J.-L., Vedie B., Lamaze C. Rab7 Is Functionally Required for Selective Cargo Sorting at the Early Endosome. Traffic. 2014;15:309&#x2013;326. doi: 10.1111/tra.12143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12143</ArticleId><ArticleId IdType="pubmed">24329906</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki T.K. FDA approval for anifrolumab in patients with lupus. Lancet Rheumatol. 2021;3:e689. doi: 10.1016/S2665-9913(21)00291-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00291-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayeva M., Khechaduri A., Puig S., Chang H.-C., Patial S., Blackshear P.J., Ardehali H. mTOR Regulates Cellular Iron Homeostasis through Tristetraprolin. Cell Metab. 2012;16:645&#x2013;657. doi: 10.1016/j.cmet.2012.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.10.001</ArticleId><ArticleId IdType="pmc">PMC3594686</ArticleId><ArticleId IdType="pubmed">23102618</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>